US20060142842A1 - Medical devices including metallic films and methods for making same - Google Patents

Medical devices including metallic films and methods for making same Download PDF

Info

Publication number
US20060142842A1
US20060142842A1 US11/025,684 US2568404A US2006142842A1 US 20060142842 A1 US20060142842 A1 US 20060142842A1 US 2568404 A US2568404 A US 2568404A US 2006142842 A1 US2006142842 A1 US 2006142842A1
Authority
US
United States
Prior art keywords
filament
endoprosthesis
length
film
metallic film
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US11/025,684
Other versions
US7901447B2 (en
Inventor
Masoud Molaei
Beren Correa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Scimed Inc
Original Assignee
Boston Scientific Scimed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US11/025,684 priority Critical patent/US7901447B2/en
Application filed by Boston Scientific Scimed Inc filed Critical Boston Scientific Scimed Inc
Priority to EP12192288.4A priority patent/EP2617387A1/en
Priority to EP05724666.2A priority patent/EP1725186B1/en
Priority to JP2007502069A priority patent/JP4712029B2/en
Priority to PCT/US2005/007173 priority patent/WO2006071245A1/en
Priority to CA2558128A priority patent/CA2558128C/en
Priority to PCT/US2005/007164 priority patent/WO2005084584A1/en
Priority to PCT/US2005/006993 priority patent/WO2006071243A1/en
Priority to EP05724762A priority patent/EP1725188A1/en
Priority to PCT/US2005/007162 priority patent/WO2005084583A2/en
Priority to JP2007502033A priority patent/JP2007526099A/en
Priority to PCT/US2005/007161 priority patent/WO2006071244A1/en
Priority to PCT/US2005/007282 priority patent/WO2005084585A1/en
Priority to EP05724667A priority patent/EP1725187A1/en
Priority to EP12192279.3A priority patent/EP2614793A1/en
Priority to JP2007502032A priority patent/JP4906710B2/en
Priority to CA2558132A priority patent/CA2558132C/en
Priority to CA2558131A priority patent/CA2558131C/en
Priority to PCT/US2005/006895 priority patent/WO2006071242A1/en
Assigned to BOSTON SCIENTIFIC SCIMED, INC. reassignment BOSTON SCIENTIFIC SCIMED, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CORREA, BEREN W., MOLAEI, MASOUD
Publication of US20060142842A1 publication Critical patent/US20060142842A1/en
Priority to US13/031,923 priority patent/US8864815B2/en
Publication of US7901447B2 publication Critical patent/US7901447B2/en
Application granted granted Critical
Priority to US14/519,685 priority patent/US9833310B2/en
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/02Inorganic materials
    • A61L31/022Metals or alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/143Stabilizers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • A61F2002/072Encapsulated stents, e.g. wire or whole stent embedded in lining
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • A61F2002/075Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S623/00Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
    • Y10S623/901Method of manufacturing prosthetic device

Definitions

  • the invention relates to medical devices, such as endoprostheses, and methods of making the devices.
  • the body includes various passageways such as arteries, other blood vessels, and other body lumens. These passageways sometimes become occluded or weakened. For example, the passageways can be occluded by a tumor, restricted by plaque, or weakened by an aneurysm. When this occurs, the passageway can be reopened or reinforced, or even replaced, with a medical endoprosthesis.
  • An endoprosthesis is typically a tubular member that is placed in a lumen in the body. Endoprostheses can be delivered inside the body by a catheter that supports the endoprosthesis in a compacted or reduced-size form as the endoprosthesis is transported to a desired site. Upon reaching the site, the endoprosthesis is expanded, for example, so that it can contact the walls of the lumen.
  • the expansion mechanism may include forcing the endoprosthesis to expand radially.
  • the expansion mechanism can include the catheter carrying a balloon, which carries a balloon-expandable endoprosthesis.
  • the balloon can be inflated to deform and to fix the expanded endoprosthesis at a predetermined position in contact with the lumen wall.
  • the balloon can then be deflated, and the catheter withdrawn.
  • the endoprosthesis is formed of an elastic material that can be reversibly compacted and expanded, e.g., elastically or through a material phase transition.
  • the endoprosthesis is restrained in a radially compacted condition.
  • the restraint is removed, for example, by retracting a restraining device such as an outer sheath, enabling the endoprosthesis to self-expand by its own internal elastic restoring force.
  • the invention relates to medical devices, such as endoprostheses, and methods of making the devices.
  • exemplary endoprostheses include stents, covered stents, and stent-grafts.
  • an endoprosthesis includes a deposited metallic film defining first and second opposed surfaces and a thickness of less than about 50 ⁇ m therebetween and at least one metal filament.
  • the at least one filament defines a length. At least a portion of the filament along its length is embedded within the deposited metallic film its first and second surfaces.
  • the deposited metallic film may include deposited titanium and nickel, e.g., an alloy including nickel and titanium.
  • the deposited film may have a substantially tubular shape defining a longitudinal axis.
  • the at least one filament may extend, e.g., linearly or helically, generally along the longitudinal axis.
  • the tubular shape of the film may define a length along the longitudinal axis and the length of the filament may be at least about 30% of the length of the tubular shape of the film.
  • the endoprosthesis may include a plurality of filaments each defining a length. At least a portion of each wire along its length may be embedded within the metallic film between the first and second surfaces. Each filament may extend generally along the longitudinal axis. The length of each filament may be at least 30% of the length of the tubular shape of the film.
  • At least 75% of the filament along its length may be embedded within the metallic film between the first and second surfaces of the metallic film.
  • the filament along its length, may include a plurality of embedded portions and at least one non-embedded portion. Each embedded portion may be embedded within the metallic film between the first and second surfaces of the metallic film. Adjacent embedded portions may be spaced apart by a non-embedded portion of the filament.
  • the substantially tubular shape may defines a circumference.
  • the at least one filament may extend at least partially about the circumference.
  • the at least one filament may be an alloy comprising nickel and titanium.
  • the metallic film and the at least one filament may each have a respective tensile strength, with the tensile strength of the filament being greater than the tensile strength of the metallic film.
  • the metallic film and the at least one filament may each have a respective, different shape set configuration.
  • the endoprosthesis may include a stent body.
  • the the stent body and the deposited film may be generally concentric.
  • an endoprosthesis includes a cover including at least one deposited metallic film.
  • the cover defines first and second opposed metallic film edges.
  • the first and second opposed metallic film edges each define a channel.
  • At least one filament may extends along the channel of each opposed metallic film edge.
  • the deposited metallic film may include deposited nickel and titanium, e.g., an alloy including nickel and titanium.
  • the cover may have a substantially tubular shape defining a longitudinal axis.
  • the at least one filament may extend generally parallel to the longitudinal axis.
  • the tubular shape may define a length along the longitudinal axis.
  • the length of the filament may be at least about 30% of the length of the tubular shape.
  • the first and second opposed edges may each define at least one offset tab.
  • the channel of each opposed edge may be formed by the offset tab.
  • the first and second opposed edges may each define a plurality of channels. Each channel may be formed by a respective offset tab.
  • the filament may extend through at least some of the channels of each opposed edge.
  • the endoprosthesis may include a stent body, At least a portion of the at least one filament and at least a portion of the stent body may be secured together.
  • the filament may define a longitudinal axis.
  • An engagement between at least one of the channels and the filament may restrict movement of the filament along its longitudinal axis with respect to the at least one of the channels.
  • the filament may have freedom of movement along its length with respect to at least one of the channels.
  • the first and second opposed edges may be a first pair of opposed edges and metallic film of the cover may define a plurality of pairs of first and second opposed edges. Each edge of each pair may define at least one channel. A respective filament may extend through the channel of each opposed edge of each pair. Each pair of opposed edges may extend generally along the longitudinal axis. Each filament may have a length at least about 30% of the length of the tubular shape. The first and second edges of each pair of opposed edges may have at least some relative freedom of movement with respect to a circumference of the cover.
  • the invention features an endoprosthesis including a metallic film, e.g., a vapor deposited film, including nickel, titanium, and chromium.
  • a metallic film e.g., a vapor deposited film
  • nickel, titanium, and chromium e.g., nickel, titanium, and chromium.
  • a ratio of a weight of chromium of the metallic film to a combined weight of nickel, titanium, and chromium of the metallic film is at least 0.001 and can be less than 0.0075.
  • FIG. 1 is a side view of an endoprosthesis in a radially expanded state as deployed within a body passage adjacent an aneurysm.
  • FIG. 2 a is a side view of a distal portion of a deployment device prior to radial expansion of the endoprosthesis.
  • FIG. 2 b is a side view of the distal portion of the deployment device subsequent to radial expansion of the endoprosthesis adjacent the aneurysm.
  • FIG. 3 a is a perspective view of an endoprosthesis.
  • FIG. 3 b is a cross-sectional view of the endoprosthesis of FIG. 3 a.
  • FIG. 4 is a top view of a cover of the endoprosthesis of FIG. 3 a .
  • the cover is shown in two-dimensions and separate from the endoprosthesis.
  • FIG. 5 a is a cross-sectional end view of the cover of FIG. 4 . Tabs of the cover have been formed into channels.
  • FIG. 5 b is the cover of FIG. 5 a .
  • the cover has been formed into a generally tubular shape.
  • FIG. 6 is a cover suitable for an endoprosthesis.
  • the cover includes tabs forming channels, which are located within a circumference of the cover.
  • FIG. 7 is an endoprosthesis having a cover formed of two cover portions.
  • FIG. 8 is a cover having channels formed via metallic film deposition.
  • FIG. 9 is a cross-sectional view of an endoprosthesis including the cover of FIG. 8 .
  • FIG. 10 a shows an endoprosthesis having a plurality of integral, longitudinally extending filaments.
  • FIG. 10 b is a cross-sectional view of the endoprosthesis of FIG. 10 a.
  • FIG. 11 is a cover suitable for an endoprosthesis.
  • the cover has a plurality of longitudinally extending filaments each having a plurality of embedded integral portions and a plurality of exposed portions.
  • an endoprosthesis 100 is deployed within a body passage, e.g., within a vessel weakened by an aneurysm, e.g., an aneurysm 25 of a vessel 26 of a human brain.
  • Endoprosthesis 100 includes a framework, e.g., a stent body 52 , covered by a tubular member or cover 54 .
  • the stent body provides a relatively rigid framework that secures the endoprosthesis at the treatment site.
  • the framework defines relatively large openings or fenestrations that contribute to the mechanical properties of the stent.
  • the cover 54 is relatively thin and flexible and includes smaller fenestrations that contribute to the mechanical properties of the cover and occlude the fenestrations of the stent.
  • the endoprosthesis 100 modifies an amount or velocity of blood passing between vessel 26 and aneurysm 25 .
  • prosthesis 100 can be deployed to reduce or block blood flow between vessel 26 and aneurysm 25 .
  • the endoprosthesis can also reduce blood flow from a feeder vessel 27 . If so deployed, prosthesis 100 may sufficiently reduce blood flow to allow clotting or other healing processes to take place within aneurysm 25 and/or opening 29 .
  • Tubular member 54 can provide a greater attenuation of the blood flow into the aneurysm 25 than stent body 52 alone.
  • Endoprosthesis 100 can allow some flow to pass between vessel 26 and aneurysm 25 even while providing some reduction in the rate and/or volume of flow.
  • Prosthesis 100 can also (or alternatively) allow blood to pass between vessel 26 containing the prosthesis and adjacent vessels, e.g., feeder vessel 27 , while still providing reduced flow with respect to the aneurysm.
  • endoprosthesis 100 is deployed to aneurysm 25 using a deployment device 30 , such as a catheter that can be threaded through a tortuous pathway.
  • the device 30 includes a retractable outer sheath 31 and an inner catheter 32 .
  • Device 30 is introduced over a guide wire 37 extending along the interior 28 of vessel 26 .
  • the endoprosthesis 100 is radially compacted between outer sheath 31 and inner catheter 32 adjacent a distal opening 40 of the outer sheath.
  • the outer sheath 31 is retracted upon reaching the desired deployment site, e.g., aneurysm 25 .
  • endoprosthesis 100 self-expands by its own internal elastic restoring force when the radially restraining outer sheath is retracted.
  • deployment of prosthesis 100 may include use of a balloon or other device to radially expand prosthesis 100 within vessel 26 .
  • the inner catheter 32 and guide wire 37 are withdrawn from vessel 26 .
  • Suitable delivery systems include the Neuroform, Neuroform2, and Wingspan Stent System available from Boston Scientific Target Therapeutics, Fremont, Calif.
  • the outer sheath and/or inner catheter includes a reinforcing member to respectively resist elongation or compression as the outer sheath is withdrawn.
  • Such reinforcing members include polymer shafts, braids, and coil structures.
  • endoprosthesis 100 Upon expansion, endoprosthesis 100 assumes a shape and radial extent generally coextensive with an inner surface of the vessel 26 , e.g., a tubular shape centered about a longitudinal axis a 1 of the prosthesis ( FIG. 1 ).
  • prosthesis 100 can have a diameter d of between, for example, 1 mm to 46 mm.
  • a prosthesis for deployment within a vessel at an aneurysm can have an expanded diameter d of from about 2 mm to about 6 mm, e.g., about 2.5 mm to about 4.5 mm.
  • prosthesis 100 can have a length along axis a 1 of at least 5 mm, at least 10 mm, e.g., at least about 30 mm.
  • An exemplary embodiment has an expanded diameter of about 3.5 mm and a length of about 15 mm.
  • the stent body has a closed cell framework, an open cell framework, a helical framework, a braided framework, or combination thereof.
  • the cover can be fixed to the stent by, e.g. fasteners.
  • Attachment techniques include brazing, welding or attachment with a filament, rivots or grommets, or crimping, or adhesive.
  • the tubular member differs from a fabric at least in that the tubular member lacks fibers than can be pushed apart to receive a filament as by sewing a fabric. Accordingly, the fenestrations can be formed prior to the process of passing the filament through the tubular member. Fenestrations that receive the filaments can be formed by, e.g., etching, laser cutting, or a photolithographic process. Attachment techniques are described in U.S. Ser. No. ______, titled MEDICAL DEVICES INCLUDING METALLIC FILMS AND METHODS FOR MAKING SAME, attorney Docket No. 10527-566001, filed contemporaneously herewith, which application is incorporated herein by reference.
  • the cover is formed of a thin film that exhibits advantageous properties such as strength, toughness, and flexibility by selection of the composition of the film, processing techniques, and mechanical configuration.
  • the film is a vapor-deposited material composed of a nickel-titanium alloy having a strength additive, e.g. chromium.
  • the film has a thickness of about 50 ⁇ m or less, e.g. about 4-35 ⁇ m, and includes fine fenestrations, which facilitate collapsing the film to small diameter for delivery into the body and expansion at the treatment site, while impeding blood access to the aneurysm.
  • the film is processed to modify dislocations, which contribute to strength and toughness of the thin film.
  • Deposited materials are formed by depositing film constituents from a suspended state, e.g. in a vapor or a vacuum onto a surface.
  • the constituents are suspended, e.g. by bombarding, heating or sputtering a bulk target.
  • the suspended constituents deposit on a substrate to form the film.
  • Deposited films can exhibit highly uniform thickness and microstructure in very thin films, e.g. about 50 ⁇ m or less, e.g. 4-35 ⁇ m.
  • Deposition techniques include sputter deposition, pulsed laser deposition, ion beam deposition and plasma deposition. Suitable deposition processes are described in Busch et al. U.S. Pat. No. 5,061,914, Bose et al. U.S. Pat. No. 6,605,111, Johnston U.S. Pat. No. 6,533,905, and Gupta et al. U.S. 2004/0014253, the entire contents of all of which are hereby incorporated by reference.
  • the deposited film is an alloy that includes nickel and titanium, and a strength additive or additives, which modify a mechanical property, e.g., a hardness or elasticity, of the film.
  • the film is a tertiary alloy that has substantially no other components besides nickel, titanium, and additive present in an amount greater than 1%, 0.5% or 0.2% or less than 20%, 10%, or 5% by weight of the film.
  • the film may consist essentially of nickel, titanium, and chromium.
  • the deposited film includes between 54 and 57 weight percent nickel with the balance composed essentially of titanium and chromium.
  • a ratio of a weight of chromium of the film to a combined weight of nickel, titanium, and chromium of the film is at least 0.001, at least 0.002 e.g., at least 0.0025.
  • the ratio of the weight of chromium of the film to the combined weight of chromium, nickel, and titanium of the film can be 0.02 or less, 0.01 or less, e.g., 0.0075 or less.
  • the ratio of the weight of chromium to the combined weight of chromium, nickel, and titanium of the film can be about 0.0025.
  • the alloy exhibits superelastic or pseudo-elastic properties.
  • a metallic film can be combined with one or more filaments in an endoprosthesis cover. Because the filaments and film may have very different mechanical properties, e.g., elongation before break and tensile strengths, the filaments and film cooperate to lend the cover desirable mechanical properties, e.g., toughness along the circumferential, radial, and/or longitudinal dimensions.
  • a filament secures portions of a film relative to other portions of the film such as to maintain the three-dimensional shape of the cover and/or to secure the film with respect to a stent body.
  • an endoprosthesis 150 includes a cover 154 encircling a stent body 152 .
  • First and second edges 157 and 159 of cover 152 define a plurality of offset tabs 156 i ( FIG. 4 ).
  • each tab defines a respective channel 158 i ( FIG. 3 a ).
  • Different channels 158 i are coaxial with one another parallel to a length 1 of cover 152 .
  • a filament 160 seen in FIG. 3 b extends within the coaxial channels along the length 1 and prevents cover 154 from unrolling by securing offset tabs 156 i relative to one another.
  • Filament 160 can include, e.g., a suture, a polymer, a textile, or a metal, e.g., a metal wire formed of gold, platinum, stainless steel, or a shape memory metal, e.g., nitinol.
  • a filament can include a combination of such materials, e.g., a composite.
  • the filament can be braided and need not have a circular configuration, e.g., the filament can be ribbon shaped.
  • the filament typically has a thickness or radial dimension of less than a thickness of the film.
  • the member is a metal wire having a diameter of about 10 ⁇ or less, about 8 ⁇ , e.g., about 5 ⁇ m or less.
  • the filament 160 can have a higher tensile strength than the film of the cover 154 .
  • a ratio of the tensile strength of the filament 160 to the tensile strength of the film is at least about 1.5, e.g., at least about 2.
  • the ratio may be about 4 or less, e.g., about 3 or less.
  • the filament may be a nitinol wire having a tensile strength of at least 200 ksi, at least 250 ksi, e.g., at least 300 ksi.
  • An exemplary metallic film has a tensile strength of 150 ksi.
  • the filament 160 includes a wire of shape memory metal that is shape set differently from a shape set of the metallic film.
  • one of the member 160 and metallic film is shape set at a configuration corresponding to the radially compressed state within a delivery device while the other of the member and film is shape set at a configuration corresponding to the radially expanded state within a body passage.
  • a primary difference in the shape set between the member 160 and the cover may be in the shape set length, with one of the member and cover having a longer shape set length than the other.
  • An exemplary method of manufacturing cover 154 includes depositing a metallic film on a substrate.
  • the cover can be provided with fenestrations 62 , which are not shown in FIG. 3 a .
  • Tabs 156 i can be formed by photolithography or machined, e.g., by laser cutting, from a larger deposited film. Referring to FIG. 5 a , each tab 156 i is turned about itself to form a respective channel 158 i . Referring to FIG. 5 b , if not deposited on a three-dimensional substrate, the film can be rolled, e.g., about a mandrel, to provide a three-dimensional shape.
  • Adjacent tabs 156 i are relatively secured by filament 160 .
  • the filament 160 can be inserted along the common axis of channels 158 i or inserted laterally through a terminal gap ⁇ g of each tab. If present, the terminal gap of each tab can be closed after introducing member 160 .
  • film 154 can be disposed with respect to a stent body, e.g., about the stent body ( FIG. 3 b ).
  • the cover and stent body can be relatively secured with, e.g., one or more filaments 59 , which pass through fenestrations of the cover and engage framework members 58 of the stent body. In embodiments, some or all of the tabs engage a portion of the stent body, e.g., a framework member 58 , to secure the cover and stent body.
  • filament 160 and some or all of tabs 156 i have little or no relative freedom of movement.
  • each tab 156 i may mechanically engage filament 160 via a tight fit between respective channel 158 i and the member 160 .
  • An adhesive or other polymer may also or alternatively be used to enhance the engagement between the filament and the channels of the tabs.
  • filament 160 and some or all of channels 158 i allow some relative freedom of movement, e.g., longitudinal or circumferential freedom of movement.
  • Longitudinal freedom of movement may be provided by a filament not tightly engaged by the channels, e.g., by a filament having a diameter smaller than an inner diameter of the channels.
  • Circumferential freedom of movement can be provided by circumferentially elongating the channels so that the cover edges 157 , 159 can move circumferentially relative to one another, e.g., toward and away from one anther.
  • Adjacent tabs 156 i and 156 i ⁇ 1 may define gaps (not shown) to allow the cover edges some relative longitudinal freedom of movement.
  • An elastic polymer may fill the channels to help retain the filament yet allow some relative movement.
  • Channels 158 i are shown as extending coaxially the entire length of the cover. In some embodiments, channels 158 i extend along only a portion of the cover length, e.g., 1 ⁇ 2 the length or less, 1 ⁇ 3 the length or less, or 1 ⁇ 4 the length or less. The resulting “shorter” channel may be located anywhere along the length of the endoprosthesis, e.g., centrally or distally or proximally relative to an implanted prosthesis.
  • Channels 158 i are shown as generally parallel with a longitudinal axis of the endoprosthesis 150 .
  • the channels 158 i and filaments can have other configurations, e.g., circumferential, curved, or helical about the endoprosthesis.
  • a cover 225 includes tabs 227 i and channels 229 i located within an external circumference of the cover. Accordingly, when relatively secured and placed concentrically with respect to a stent body, the cover forms a relatively smooth outer surface with little or no ridge-like protrusion resulting from the tabs 227 i .
  • Channels 229 i may also be used to engage a framework member 58 of a stent body, which engagement can secure the cover and stent body.
  • a cover 175 having first and second cover portions 177 , 179 encircles a stent body having framework members 58 .
  • Each cover portion defines first and second edges.
  • First edges and second edges of cover portions 177 , 179 are secured to one another by first and second sets of offset tabs 181 i , 183 i , which form respective channels 182 i , 184 i .
  • the channels of different tabs are coaxial aligned and extend along at least a portion of the length of the endoprosthesis.
  • a filament 160 extends along the coaxial channels.
  • Cover portions 177 , 179 may have some freedom of movement relative to one another. For example, by allowing longitudinal or circumferential freedom of movement between different cover portions, an endoprosthesis can accommodate delivery or deployment within a tortuous body passage having small radius curves. Freedom of movement between the cover portions can be provided using, e.g., the techniques described for providing relative freedom of movement between a filament and cover.
  • an endoprosthesis cover 200 includes tabs having integral channels 208 i formed by, e.g., three-dimensional deposition over a sacrificial medium. Each integral channel defines a complete circumference without a seam resulting from mechanical channel formation.
  • An endoprosthesis 201 is formed by positioning the cover 200 about a stent body having framework members 58 and securing the tabs with a filament 160 ( FIG. 9 ).
  • An exemplary method of manufacturing cover 200 includes depositing a first layer of metallic film on a substrate, whether two- or three-dimensional.
  • a sacrificial medium e.g., chromium
  • the sacrificial medium is photolithographically deposited over portions of the previously deposited film.
  • the sacrificial medium is formed of a material, e.g., chromium, that can be removed, e.g., by etching, from the metallic film without damage thereto. Additional material of the metallic film is deposited over the sacrificial medium to complete the film. Subsequently, the sacrificial medium is removed from the remaining film leaving behind the integral channels.
  • a cover 300 (shown without a stent body) includes longitudinal channels 302 each formed by depositing metal about a filament 160 .
  • the filament is typically a metal ribbon or wire, e.g., a metal wire of shape memory alloy. Depositing the metallic film about the wire secures the two together and ensures that the mechanical properties of each are communicated to the other without losses resulting from slippage.
  • filaments 160 are shown as extending linearly along the longitudinal axis of the endprosthesis, one or more of the filaments can have other longitudinally extending configurations, e.g., circumferential, curved, or helical. Filaments may intersect or cross one another. In other embodiments, some or all the wires do not intersect or cross another wire.
  • An exemplary method for forming cover 300 includes depositing a first layer of metallic film. Wires 160 are positioned adjacent the deposited film. Additional metal is deposited over the wires to integrate the wires and film. In an alternative method, wires 160 are positioned over a substrate. A first amount of metallic film is deposited over the wires and substrate. Subsequently, the first amount of film and substrate are separated and additional metal film is deposited to integrate the wires and film.
  • a cover 325 includes a plurality of partially exposed filaments 160 . Portions of the filaments 160 are embedded within a deposited metallic film of the cover and other portions of the filaments are left exposed. When formed about a stent body, the exposed portions of wire 160 can engage framework members of the stent body to secure the cover and stent body together. Another filament, e.g., a suture or wire, can be threaded through exposed portions of filaments 160 to secure the cover to a stent body or to retain the cover in a three-dimensional shape.
  • a suture or wire can be threaded through exposed portions of filaments 160 to secure the cover to a stent body or to retain the cover in a three-dimensional shape.
  • a deposited thin film and including one or more filaments is useable as an endoprosthesis without a supporting stent.
  • an endoprosthesis without a supporting stent can include a deposited thin film including one or more at least partially embedded wires contributing to radial and/or longitudinal strength of the film.
  • the filaments whether embedded or not, extend beyond an end of the endoprosthesis.
  • the extending filaments can be used to, e.g., re-sheath the endoprosthesis in order to change its position or withdraw it from a lumen, or to pull the endoprosthesis along a body lumen.
  • an endoprosthesis has a generally tubular shape.
  • the endoprosthesis (or stent body 52 or tubular member 54 individually) has or includes other shapes such as conical, oblate, and branched.
  • the endoprosthesis may have a closed end to form, e.g., a basket shape.
  • Thin films discussed above, composed of Ni—Ti-strength additive alloys and/or with modified microstructures, can be used in other applications. Examples include baskets, filters, catheters, guidewires, and medical balloons, such as an angioplasty balloon. Filaments of such endoprostheses may intersect or be woven to define a shape of the endoprosthesis.
  • An endoprosthesis may include a cover disposed externally to a framework as shown and/or internally of a framework. Endoprostheses having a cover including, e.g., a deposited thin film, disposed internally of a framework are described in U.S. patent application Ser. No. **/***,***, attorney docket no. 10527-567001, titled MEDICAL DEVICES INCLUDING METALLIC FILMS AND METHODS FOR MAKING SAME, and filed concurrently herewith, which application is incorporated herein by reference.
  • An endoprosthesis may include features to enhance a flexibility of the endoprosthesis as described in U.S. patent application Ser. No. **/***,***, attorney docket no. 10527-568001, titled MEDICAL DEVICES INCLUDING METALLIC FILMS AND METHODS FOR MAKING SAME, and filed concurrently herewith, which application is incorporated herein by reference.
  • composition and/or fabrication method of a deposited thin film of an endoprosthesis may include features that enhance a strength or toughness of the film as described in U.S. patent application Ser. No. **,***,***, attorney docket no. 10527-570001, titled MEDICAL DEVICES INCLUDING METALLIC FILMS AND METHODS FOR MAKING SAME, and filed concurrently herewith, which application is incorporated herein by reference.
  • An endoprosthesis may include a deposited thin film and a polymer as described in U.S. patent application Ser. No. **,***,***, attorney docket no. 10527-596001, titled MEDICAL DEVICES INCLUDING METALLIC FILMS AND METHODS FOR MAKING SAME, and filed concurrently herewith, which application is incorporated herein by reference.

Abstract

Medical devices, such as endoprostheses, and methods of making the devices are disclosed. The medical device can include a composite cover formed of a deposited metallic film. The cover may include one or more filaments, e.g., wires, which cooperate with the film to provide desirable mechanical properties. The wires may be integrated with the film by depositing the film over the wires.

Description

    FIELD OF THE INVENTION
  • The invention relates to medical devices, such as endoprostheses, and methods of making the devices.
  • BACKGROUND
  • The body includes various passageways such as arteries, other blood vessels, and other body lumens. These passageways sometimes become occluded or weakened. For example, the passageways can be occluded by a tumor, restricted by plaque, or weakened by an aneurysm. When this occurs, the passageway can be reopened or reinforced, or even replaced, with a medical endoprosthesis. An endoprosthesis is typically a tubular member that is placed in a lumen in the body. Endoprostheses can be delivered inside the body by a catheter that supports the endoprosthesis in a compacted or reduced-size form as the endoprosthesis is transported to a desired site. Upon reaching the site, the endoprosthesis is expanded, for example, so that it can contact the walls of the lumen.
  • The expansion mechanism may include forcing the endoprosthesis to expand radially. For example, the expansion mechanism can include the catheter carrying a balloon, which carries a balloon-expandable endoprosthesis. The balloon can be inflated to deform and to fix the expanded endoprosthesis at a predetermined position in contact with the lumen wall. The balloon can then be deflated, and the catheter withdrawn.
  • In another delivery technique, the endoprosthesis is formed of an elastic material that can be reversibly compacted and expanded, e.g., elastically or through a material phase transition. During introduction into the body, the endoprosthesis is restrained in a radially compacted condition. Upon reaching the desired implantation site, the restraint is removed, for example, by retracting a restraining device such as an outer sheath, enabling the endoprosthesis to self-expand by its own internal elastic restoring force.
  • SUMMARY OF THE INVENTION
  • The invention relates to medical devices, such as endoprostheses, and methods of making the devices. Exemplary endoprostheses include stents, covered stents, and stent-grafts.
  • In some embodiments, an endoprosthesis includes a deposited metallic film defining first and second opposed surfaces and a thickness of less than about 50 μm therebetween and at least one metal filament. The at least one filament defines a length. At least a portion of the filament along its length is embedded within the deposited metallic film its first and second surfaces.
  • The deposited metallic film may include deposited titanium and nickel, e.g., an alloy including nickel and titanium.
  • The deposited film may have a substantially tubular shape defining a longitudinal axis. The at least one filament may extend, e.g., linearly or helically, generally along the longitudinal axis.
  • The tubular shape of the film may define a length along the longitudinal axis and the length of the filament may be at least about 30% of the length of the tubular shape of the film.
  • The endoprosthesis may include a plurality of filaments each defining a length. At least a portion of each wire along its length may be embedded within the metallic film between the first and second surfaces. Each filament may extend generally along the longitudinal axis. The length of each filament may be at least 30% of the length of the tubular shape of the film.
  • At least 75% of the filament along its length may be embedded within the metallic film between the first and second surfaces of the metallic film.
  • The filament, along its length, may include a plurality of embedded portions and at least one non-embedded portion. Each embedded portion may be embedded within the metallic film between the first and second surfaces of the metallic film. Adjacent embedded portions may be spaced apart by a non-embedded portion of the filament.
  • The substantially tubular shape may defines a circumference. The at least one filament may extend at least partially about the circumference.
  • The at least one filament may be an alloy comprising nickel and titanium.
  • The metallic film and the at least one filament may each have a respective tensile strength, with the tensile strength of the filament being greater than the tensile strength of the metallic film. The metallic film and the at least one filament may each have a respective, different shape set configuration.
  • The endoprosthesis may include a stent body. The the stent body and the deposited film may be generally concentric.
  • In some embodiments, an endoprosthesis includes a cover including at least one deposited metallic film. The cover defines first and second opposed metallic film edges. The first and second opposed metallic film edges each define a channel. At least one filament may extends along the channel of each opposed metallic film edge.
  • The deposited metallic film may include deposited nickel and titanium, e.g., an alloy including nickel and titanium.
  • The cover may have a substantially tubular shape defining a longitudinal axis. The at least one filament may extend generally parallel to the longitudinal axis. The tubular shape may define a length along the longitudinal axis. The length of the filament may be at least about 30% of the length of the tubular shape.
  • The first and second opposed edges may each define at least one offset tab. The channel of each opposed edge may be formed by the offset tab.
  • The first and second opposed edges may each define a plurality of channels. Each channel may be formed by a respective offset tab. The filament may extend through at least some of the channels of each opposed edge.
  • The endoprosthesis may include a stent body, At least a portion of the at least one filament and at least a portion of the stent body may be secured together.
  • The filament may define a longitudinal axis. An engagement between at least one of the channels and the filament may restrict movement of the filament along its longitudinal axis with respect to the at least one of the channels. The filament may have freedom of movement along its length with respect to at least one of the channels.
  • The first and second opposed edges may be a first pair of opposed edges and metallic film of the cover may define a plurality of pairs of first and second opposed edges. Each edge of each pair may define at least one channel. A respective filament may extend through the channel of each opposed edge of each pair. Each pair of opposed edges may extend generally along the longitudinal axis. Each filament may have a length at least about 30% of the length of the tubular shape. The first and second edges of each pair of opposed edges may have at least some relative freedom of movement with respect to a circumference of the cover.
  • In one aspect, the invention features an endoprosthesis including a metallic film, e.g., a vapor deposited film, including nickel, titanium, and chromium. A ratio of a weight of chromium of the metallic film to a combined weight of nickel, titanium, and chromium of the metallic film is at least 0.001 and can be less than 0.0075.
  • Other aspects, features, and advantages of the invention will be apparent from the description of the preferred embodiments thereof and from the claims.
  • BRIEF DESCRIPTION OF THE FIGURES
  • FIG. 1 is a side view of an endoprosthesis in a radially expanded state as deployed within a body passage adjacent an aneurysm.
  • FIG. 2 a is a side view of a distal portion of a deployment device prior to radial expansion of the endoprosthesis.
  • FIG. 2 b is a side view of the distal portion of the deployment device subsequent to radial expansion of the endoprosthesis adjacent the aneurysm.
  • FIG. 3 a is a perspective view of an endoprosthesis.
  • FIG. 3 b is a cross-sectional view of the endoprosthesis of FIG. 3 a.
  • FIG. 4 is a top view of a cover of the endoprosthesis of FIG. 3 a. The cover is shown in two-dimensions and separate from the endoprosthesis.
  • FIG. 5 a is a cross-sectional end view of the cover of FIG. 4. Tabs of the cover have been formed into channels.
  • FIG. 5 b is the cover of FIG. 5 a. The cover has been formed into a generally tubular shape.
  • FIG. 6 is a cover suitable for an endoprosthesis. The cover includes tabs forming channels, which are located within a circumference of the cover.
  • FIG. 7 is an endoprosthesis having a cover formed of two cover portions.
  • FIG. 8 is a cover having channels formed via metallic film deposition.
  • FIG. 9 is a cross-sectional view of an endoprosthesis including the cover of FIG. 8.
  • FIG. 10 a shows an endoprosthesis having a plurality of integral, longitudinally extending filaments.
  • FIG. 10 b is a cross-sectional view of the endoprosthesis of FIG. 10 a.
  • FIG. 11 is a cover suitable for an endoprosthesis. The cover has a plurality of longitudinally extending filaments each having a plurality of embedded integral portions and a plurality of exposed portions.
  • DETAILED DESCRIPTION
  • Referring to FIG. 1, an endoprosthesis 100 is deployed within a body passage, e.g., within a vessel weakened by an aneurysm, e.g., an aneurysm 25 of a vessel 26 of a human brain. Endoprosthesis 100 includes a framework, e.g., a stent body 52, covered by a tubular member or cover 54. The stent body provides a relatively rigid framework that secures the endoprosthesis at the treatment site. The framework defines relatively large openings or fenestrations that contribute to the mechanical properties of the stent. The cover 54 is relatively thin and flexible and includes smaller fenestrations that contribute to the mechanical properties of the cover and occlude the fenestrations of the stent.
  • The endoprosthesis 100 modifies an amount or velocity of blood passing between vessel 26 and aneurysm 25. For example, prosthesis 100 can be deployed to reduce or block blood flow between vessel 26 and aneurysm 25. The endoprosthesis can also reduce blood flow from a feeder vessel 27. If so deployed, prosthesis 100 may sufficiently reduce blood flow to allow clotting or other healing processes to take place within aneurysm 25 and/or opening 29. Tubular member 54 can provide a greater attenuation of the blood flow into the aneurysm 25 than stent body 52 alone. Endoprosthesis 100, however, can allow some flow to pass between vessel 26 and aneurysm 25 even while providing some reduction in the rate and/or volume of flow. Prosthesis 100 can also (or alternatively) allow blood to pass between vessel 26 containing the prosthesis and adjacent vessels, e.g., feeder vessel 27, while still providing reduced flow with respect to the aneurysm.
  • Referring to FIGS. 2 a and 2 b, endoprosthesis 100 is deployed to aneurysm 25 using a deployment device 30, such as a catheter that can be threaded through a tortuous pathway. The device 30 includes a retractable outer sheath 31 and an inner catheter 32. Device 30 is introduced over a guide wire 37 extending along the interior 28 of vessel 26. During introduction, the endoprosthesis 100 is radially compacted between outer sheath 31 and inner catheter 32 adjacent a distal opening 40 of the outer sheath.
  • Referring particularly to FIG. 2 b, the outer sheath 31 is retracted upon reaching the desired deployment site, e.g., aneurysm 25. In some embodiments, endoprosthesis 100 self-expands by its own internal elastic restoring force when the radially restraining outer sheath is retracted. Alternatively, or in combination with self-expansion, deployment of prosthesis 100 may include use of a balloon or other device to radially expand prosthesis 100 within vessel 26. After deploying the endoprosthesis, the inner catheter 32 and guide wire 37 are withdrawn from vessel 26. Suitable delivery systems include the Neuroform, Neuroform2, and Wingspan Stent System available from Boston Scientific Target Therapeutics, Fremont, Calif. In embodiments, the outer sheath and/or inner catheter includes a reinforcing member to respectively resist elongation or compression as the outer sheath is withdrawn. Such reinforcing members include polymer shafts, braids, and coil structures.
  • Upon expansion, endoprosthesis 100 assumes a shape and radial extent generally coextensive with an inner surface of the vessel 26, e.g., a tubular shape centered about a longitudinal axis a1 of the prosthesis (FIG. 1). Depending upon the application, prosthesis 100 can have a diameter d of between, for example, 1 mm to 46 mm. In certain embodiments, a prosthesis for deployment within a vessel at an aneurysm can have an expanded diameter d of from about 2 mm to about 6 mm, e.g., about 2.5 mm to about 4.5 mm. Depending upon the application, prosthesis 100 can have a length along axis a1 of at least 5 mm, at least 10 mm, e.g., at least about 30 mm. An exemplary embodiment has an expanded diameter of about 3.5 mm and a length of about 15 mm. In embodiments, the stent body has a closed cell framework, an open cell framework, a helical framework, a braided framework, or combination thereof.
  • The cover can be fixed to the stent by, e.g. fasteners. Attachment techniques include brazing, welding or attachment with a filament, rivots or grommets, or crimping, or adhesive. In some embodiments, the tubular member differs from a fabric at least in that the tubular member lacks fibers than can be pushed apart to receive a filament as by sewing a fabric. Accordingly, the fenestrations can be formed prior to the process of passing the filament through the tubular member. Fenestrations that receive the filaments can be formed by, e.g., etching, laser cutting, or a photolithographic process. Attachment techniques are described in U.S. Ser. No. ______, titled MEDICAL DEVICES INCLUDING METALLIC FILMS AND METHODS FOR MAKING SAME, attorney Docket No. 10527-566001, filed contemporaneously herewith, which application is incorporated herein by reference.
  • The cover is formed of a thin film that exhibits advantageous properties such as strength, toughness, and flexibility by selection of the composition of the film, processing techniques, and mechanical configuration. For example, in particular embodiments, the film is a vapor-deposited material composed of a nickel-titanium alloy having a strength additive, e.g. chromium. The film has a thickness of about 50 μm or less, e.g. about 4-35 μm, and includes fine fenestrations, which facilitate collapsing the film to small diameter for delivery into the body and expansion at the treatment site, while impeding blood access to the aneurysm. In particular embodiments, the film is processed to modify dislocations, which contribute to strength and toughness of the thin film.
  • Deposited materials are formed by depositing film constituents from a suspended state, e.g. in a vapor or a vacuum onto a surface. In embodiments, the constituents are suspended, e.g. by bombarding, heating or sputtering a bulk target. The suspended constituents deposit on a substrate to form the film. Deposited films can exhibit highly uniform thickness and microstructure in very thin films, e.g. about 50 μm or less, e.g. 4-35 μm. Deposition techniques include sputter deposition, pulsed laser deposition, ion beam deposition and plasma deposition. Suitable deposition processes are described in Busch et al. U.S. Pat. No. 5,061,914, Bose et al. U.S. Pat. No. 6,605,111, Johnston U.S. Pat. No. 6,533,905, and Gupta et al. U.S. 2004/0014253, the entire contents of all of which are hereby incorporated by reference.
  • In particular embodiments, the deposited film is an alloy that includes nickel and titanium, and a strength additive or additives, which modify a mechanical property, e.g., a hardness or elasticity, of the film. In particular embodiments, the film is a tertiary alloy that has substantially no other components besides nickel, titanium, and additive present in an amount greater than 1%, 0.5% or 0.2% or less than 20%, 10%, or 5% by weight of the film. The film may consist essentially of nickel, titanium, and chromium. In embodiments, the deposited film includes between 54 and 57 weight percent nickel with the balance composed essentially of titanium and chromium. In some embodiments, a ratio of a weight of chromium of the film to a combined weight of nickel, titanium, and chromium of the film is at least 0.001, at least 0.002 e.g., at least 0.0025. The ratio of the weight of chromium of the film to the combined weight of chromium, nickel, and titanium of the film can be 0.02 or less, 0.01 or less, e.g., 0.0075 or less. The ratio of the weight of chromium to the combined weight of chromium, nickel, and titanium of the film can be about 0.0025. In embodiments, the alloy exhibits superelastic or pseudo-elastic properties. Superelastic or pseudo-elastic metal alloy, as described, for example, in Schetsky, L. McDonald, “Shape Memory Alloys,” Encyclopedia of Chemical Technology (3rd ed.), John Wiley & Sons, 1982, vol. 20. pp. 726-736; and commonly assigned U.S. Ser. No. 10/346,487, filed Jan. 17, 2003.
  • A metallic film can be combined with one or more filaments in an endoprosthesis cover. Because the filaments and film may have very different mechanical properties, e.g., elongation before break and tensile strengths, the filaments and film cooperate to lend the cover desirable mechanical properties, e.g., toughness along the circumferential, radial, and/or longitudinal dimensions. In embodiments, a filament secures portions of a film relative to other portions of the film such as to maintain the three-dimensional shape of the cover and/or to secure the film with respect to a stent body.
  • Referring to FIGS. 3 a, 3 b, and 4, an endoprosthesis 150 includes a cover 154 encircling a stent body 152. First and second edges 157 and 159 of cover 152 define a plurality of offset tabs 156 i (FIG. 4). When formed as a cover, each tab defines a respective channel 158 i (FIG. 3 a). Different channels 158 i are coaxial with one another parallel to a length 1 of cover 152. A filament 160 seen in FIG. 3 b extends within the coaxial channels along the length 1 and prevents cover 154 from unrolling by securing offset tabs 156 i relative to one another.
  • Filament 160 can include, e.g., a suture, a polymer, a textile, or a metal, e.g., a metal wire formed of gold, platinum, stainless steel, or a shape memory metal, e.g., nitinol. A filament can include a combination of such materials, e.g., a composite. The filament can be braided and need not have a circular configuration, e.g., the filament can be ribbon shaped. The filament typically has a thickness or radial dimension of less than a thickness of the film. In embodiments, the member is a metal wire having a diameter of about 10 μ or less, about 8μ, e.g., about 5 μm or less.
  • The filament 160 can have a higher tensile strength than the film of the cover 154. In embodiments, a ratio of the tensile strength of the filament 160 to the tensile strength of the film is at least about 1.5, e.g., at least about 2. The ratio may be about 4 or less, e.g., about 3 or less. The filament may be a nitinol wire having a tensile strength of at least 200 ksi, at least 250 ksi, e.g., at least 300 ksi. An exemplary metallic film has a tensile strength of 150 ksi.
  • In some embodiments, the filament 160 includes a wire of shape memory metal that is shape set differently from a shape set of the metallic film. In some embodiments, one of the member 160 and metallic film is shape set at a configuration corresponding to the radially compressed state within a delivery device while the other of the member and film is shape set at a configuration corresponding to the radially expanded state within a body passage. A primary difference in the shape set between the member 160 and the cover may be in the shape set length, with one of the member and cover having a longer shape set length than the other.
  • An exemplary method of manufacturing cover 154 includes depositing a metallic film on a substrate. The cover can be provided with fenestrations 62, which are not shown in FIG. 3 a. Tabs 156 i can be formed by photolithography or machined, e.g., by laser cutting, from a larger deposited film. Referring to FIG. 5 a, each tab 156 i is turned about itself to form a respective channel 158 i. Referring to FIG. 5 b, if not deposited on a three-dimensional substrate, the film can be rolled, e.g., about a mandrel, to provide a three-dimensional shape.
  • Adjacent tabs 156 i are relatively secured by filament 160. The filament 160 can be inserted along the common axis of channels 158 i or inserted laterally through a terminal gap Δg of each tab. If present, the terminal gap of each tab can be closed after introducing member 160. Either before or after positioning filament 160 with respect to tabs 156 i, film 154 can be disposed with respect to a stent body, e.g., about the stent body (FIG. 3 b). The cover and stent body can be relatively secured with, e.g., one or more filaments 59, which pass through fenestrations of the cover and engage framework members 58 of the stent body. In embodiments, some or all of the tabs engage a portion of the stent body, e.g., a framework member 58, to secure the cover and stent body.
  • In some embodiments, filament 160 and some or all of tabs 156 i have little or no relative freedom of movement. For example, each tab 156 i may mechanically engage filament 160 via a tight fit between respective channel 158 i and the member 160. An adhesive or other polymer may also or alternatively be used to enhance the engagement between the filament and the channels of the tabs.
  • In embodiments, filament 160 and some or all of channels 158 i allow some relative freedom of movement, e.g., longitudinal or circumferential freedom of movement. During radial compression and expansion of an endoprosthesis, the cover 154 and filament 160 move relatively to accommodate different length changes without deforming the cover or endoprosthesis. Longitudinal freedom of movement may be provided by a filament not tightly engaged by the channels, e.g., by a filament having a diameter smaller than an inner diameter of the channels. Circumferential freedom of movement can be provided by circumferentially elongating the channels so that the cover edges 157,159 can move circumferentially relative to one another, e.g., toward and away from one anther. Adjacent tabs 156 i and 156 i±1 may define gaps (not shown) to allow the cover edges some relative longitudinal freedom of movement. An elastic polymer may fill the channels to help retain the filament yet allow some relative movement.
  • Channels 158 i are shown as extending coaxially the entire length of the cover. In some embodiments, channels 158 i extend along only a portion of the cover length, e.g., ½ the length or less, ⅓ the length or less, or ¼ the length or less. The resulting “shorter” channel may be located anywhere along the length of the endoprosthesis, e.g., centrally or distally or proximally relative to an implanted prosthesis.
  • Channels 158 i are shown as generally parallel with a longitudinal axis of the endoprosthesis 150. In embodiments, the channels 158 i and filaments can have other configurations, e.g., circumferential, curved, or helical about the endoprosthesis.
  • Referring to FIG. 6, a cover 225 includes tabs 227 i and channels 229 i located within an external circumference of the cover. Accordingly, when relatively secured and placed concentrically with respect to a stent body, the cover forms a relatively smooth outer surface with little or no ridge-like protrusion resulting from the tabs 227 i . Channels 229 i may also be used to engage a framework member 58 of a stent body, which engagement can secure the cover and stent body.
  • Referring to FIG. 7, a cover 175 having first and second cover portions 177,179 encircles a stent body having framework members 58. Each cover portion defines first and second edges. First edges and second edges of cover portions 177,179 are secured to one another by first and second sets of offset tabs 181 i,183 i, which form respective channels 182 i,184 i. The channels of different tabs are coaxial aligned and extend along at least a portion of the length of the endoprosthesis. A filament 160 extends along the coaxial channels. Although only two cover portions are shown, an endoprosthesis can have even more cover portions, e.g., 3 or more, 4 or more, or 5 or more, which combine to form a generally tubular cover.
  • Cover portions 177,179 may have some freedom of movement relative to one another. For example, by allowing longitudinal or circumferential freedom of movement between different cover portions, an endoprosthesis can accommodate delivery or deployment within a tortuous body passage having small radius curves. Freedom of movement between the cover portions can be provided using, e.g., the techniques described for providing relative freedom of movement between a filament and cover.
  • Referring to FIGS. 8 and 9, an endoprosthesis cover 200 includes tabs having integral channels 208 i formed by, e.g., three-dimensional deposition over a sacrificial medium. Each integral channel defines a complete circumference without a seam resulting from mechanical channel formation. An endoprosthesis 201 is formed by positioning the cover 200 about a stent body having framework members 58 and securing the tabs with a filament 160 (FIG. 9).
  • An exemplary method of manufacturing cover 200 includes depositing a first layer of metallic film on a substrate, whether two- or three-dimensional. A sacrificial medium, e.g., chromium, is photolithographically deposited over portions of the previously deposited film. The sacrificial medium is formed of a material, e.g., chromium, that can be removed, e.g., by etching, from the metallic film without damage thereto. Additional material of the metallic film is deposited over the sacrificial medium to complete the film. Subsequently, the sacrificial medium is removed from the remaining film leaving behind the integral channels.
  • Referring to FIGS. 10 a and 10 b, a cover 300 (shown without a stent body) includes longitudinal channels 302 each formed by depositing metal about a filament 160. In this embodiment, the filament is typically a metal ribbon or wire, e.g., a metal wire of shape memory alloy. Depositing the metallic film about the wire secures the two together and ensures that the mechanical properties of each are communicated to the other without losses resulting from slippage. Although filaments 160 are shown as extending linearly along the longitudinal axis of the endprosthesis, one or more of the filaments can have other longitudinally extending configurations, e.g., circumferential, curved, or helical. Filaments may intersect or cross one another. In other embodiments, some or all the wires do not intersect or cross another wire.
  • An exemplary method for forming cover 300 includes depositing a first layer of metallic film. Wires 160 are positioned adjacent the deposited film. Additional metal is deposited over the wires to integrate the wires and film. In an alternative method, wires 160 are positioned over a substrate. A first amount of metallic film is deposited over the wires and substrate. Subsequently, the first amount of film and substrate are separated and additional metal film is deposited to integrate the wires and film.
  • Referring to FIG. 11, a cover 325 includes a plurality of partially exposed filaments 160. Portions of the filaments 160 are embedded within a deposited metallic film of the cover and other portions of the filaments are left exposed. When formed about a stent body, the exposed portions of wire 160 can engage framework members of the stent body to secure the cover and stent body together. Another filament, e.g., a suture or wire, can be threaded through exposed portions of filaments 160 to secure the cover to a stent body or to retain the cover in a three-dimensional shape.
  • In some embodiments, a deposited thin film and including one or more filaments is useable as an endoprosthesis without a supporting stent. For example, an endoprosthesis without a supporting stent can include a deposited thin film including one or more at least partially embedded wires contributing to radial and/or longitudinal strength of the film.
  • In some embodiments, the filaments, whether embedded or not, extend beyond an end of the endoprosthesis. The extending filaments can be used to, e.g., re-sheath the endoprosthesis in order to change its position or withdraw it from a lumen, or to pull the endoprosthesis along a body lumen.
  • In the embodiment shown, an endoprosthesis has a generally tubular shape. In some embodiments, however, the endoprosthesis (or stent body 52 or tubular member 54 individually) has or includes other shapes such as conical, oblate, and branched. The endoprosthesis may have a closed end to form, e.g., a basket shape. Thin films, discussed above, composed of Ni—Ti-strength additive alloys and/or with modified microstructures, can be used in other applications. Examples include baskets, filters, catheters, guidewires, and medical balloons, such as an angioplasty balloon. Filaments of such endoprostheses may intersect or be woven to define a shape of the endoprosthesis.
  • Other examples of endoprostheses including a thin film as well as related systems and methods are described in U.S. provisional patent application No. 60/549,287, filed Mar. 2, 2004, which application is incorporated herein by reference.
  • An endoprosthesis may include a cover disposed externally to a framework as shown and/or internally of a framework. Endoprostheses having a cover including, e.g., a deposited thin film, disposed internally of a framework are described in U.S. patent application Ser. No. **/***,***, attorney docket no. 10527-567001, titled MEDICAL DEVICES INCLUDING METALLIC FILMS AND METHODS FOR MAKING SAME, and filed concurrently herewith, which application is incorporated herein by reference.
  • An endoprosthesis may include features to enhance a flexibility of the endoprosthesis as described in U.S. patent application Ser. No. **/***,***, attorney docket no. 10527-568001, titled MEDICAL DEVICES INCLUDING METALLIC FILMS AND METHODS FOR MAKING SAME, and filed concurrently herewith, which application is incorporated herein by reference.
  • The composition and/or fabrication method of a deposited thin film of an endoprosthesis may include features that enhance a strength or toughness of the film as described in U.S. patent application Ser. No. **,***,***, attorney docket no. 10527-570001, titled MEDICAL DEVICES INCLUDING METALLIC FILMS AND METHODS FOR MAKING SAME, and filed concurrently herewith, which application is incorporated herein by reference.
  • An endoprosthesis may include a deposited thin film and a polymer as described in U.S. patent application Ser. No. **,***,***, attorney docket no. 10527-596001, titled MEDICAL DEVICES INCLUDING METALLIC FILMS AND METHODS FOR MAKING SAME, and filed concurrently herewith, which application is incorporated herein by reference.
  • Methods for loading an endoprosthesis into a delivery device and systems for delivering an endoprosthesis to a treatment site are described in U.S. patent application Ser. No. **/***,***, attorney docket no. 10527-569001, titled MEDICAL DEVICES INCLUDING METALLIC FILMS AND METHODS FOR LOADING AND DEPLOYING SAME, which application is incorporated herein by reference.
  • All publications, references, applications, and patents referred to herein are incorporated by reference in their entirety.
  • Other embodiments are within the claims.

Claims (20)

1. An endoprosthesis, comprising:
a deposited metallic film defining first and second opposed surfaces and a thickness of less than about 50 μm therebetween; and
at least one metal filament, the at least one filament defining a length, at least a portion of the filament along its length being embedded within the metal metallic film between the first and second surfaces.
2. The endoprosthesis of claim 1, wherein the deposited metallic film comprises deposited titanium and nickel.
3. The endoprosthesis of claim 1, wherein the deposited film has a substantially tubular shape defining a longitudinal axis and the at least one filament extends generally along the longitudinal axis.
4. The endoprosthesis of claim 3, wherein the tubular shape of the film defines a length along the longitudinal axis and the length of the filament is at least about 30% of the length of the tubular shape of the film.
5. The endoprosthesis of claim 4, comprising a plurality of filaments each defining a length, at least a portion of each wire along its length being embedded within the metal alloy between the first and second surfaces of the metallic film, each filament extending generally along the longitudinal axis, the length of each filament being at least 30% of the length of the tubular shape of the film.
6. The endoprosthesis of claim 4, wherein at least 75% of the filament along its length is embedded within the metal alloy between the first and second surfaces of the metallic film.
7. The endoprosthesis of claim 4, wherein the filament, along its length, comprises a plurality of embedded portions and at least one non-embedded portion, each embedded portion being embedded within the metal alloy between the first and second surfaces of the metallic film, adjacent embedded portions being spaced apart by a non-embedded portion of the filament.
8. The endoprosthesis of claim 4, wherein the at least one filament comprises an alloy comprising nickel and titanium.
9. The endoprosthesis of claim 8, wherein the metallic film and the at least one filament each have a respective tensile strength, the tensile strength of the filament being greater than the tensile strength of the metallic film.
10. An endoprosthesis, comprising:
a cover comprising at least one deposited metallic film, the cover defining first and second opposed metallic film edges, the first and second opposed metallic film edges each defining a channel; and
at least one filament, the at least one filament extending through the channel of each opposed metallic film edge.
11. The endoprosthesis of claim 10, wherein the deposited metallic film comprises deposited nickel and titanium.
12. The endoprosthesis of claim 10, wherein the cover has a substantially tubular shape defining a longitudinal axis and the at least one filament extends generally parallel to the longitudinal axis.
13. The endoprosthesis of claim 12, wherein the tubular shape defines a length along the longitudinal axis and the length of the filament is at least about 30% of the length of the shape.
14. The endoprosthesis of claim 12, wherein the first and second opposed edges each define at least one offset tab, the channel of each opposed edge being formed by the offset tab.
15. The endoprosthesis of claim 14, wherein the first and second opposed edges each define a plurality of channels, each channel being formed by a respective offset tab, the filament extending through at least some of the channels of each opposed edge.
16. The endoprosthesis of claim 12, wherein endoprosthesis comprises a stent body, at least a portion of the at least one filament and at least a portion of the stent body being secured together.
17. The endoprosthesis of claim 12, wherein the filament defines a longitudinal axis, an engagement between at least one of the channels and the filament restricting movement of the filament along its longitudinal axis with respect to the at least one of the channels.
18. The endoprosthesis of claim 12, wherein the first and second opposed edges are a first pair of opposed edges and metallic film of the cover defines a plurality of pairs of first and second opposed edges, each edge of each pair defining at least one channel, a respective filament extending through the channel of each opposed edge of each pair.
19. The endoprosthesis of claim 18, wherein each pair of opposed edges extends generally along the longitudinal axis and each filament has a length at least about 30% of the length of the tubular shape.
20. The endoprosthesis of claim 19, wherein the first and second edges of each pair of opposed edges have at least some relative freedom of movement with respect to a circumference of the cover.
US11/025,684 2004-03-02 2004-12-29 Medical devices including a metallic film and at least one filament Active 2026-06-17 US7901447B2 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
US11/025,684 US7901447B2 (en) 2004-12-29 2004-12-29 Medical devices including a metallic film and at least one filament
EP12192279.3A EP2614793A1 (en) 2004-03-02 2005-03-02 Medical devices including metallic films and methods for making same
EP05724666.2A EP1725186B1 (en) 2004-03-02 2005-03-02 Medical devices including metallic films and methods for making same
JP2007502032A JP4906710B2 (en) 2004-03-02 2005-03-02 Medical device comprising a metal film and a polymer layer
CA2558128A CA2558128C (en) 2004-03-02 2005-03-02 Medical devices including metallic films and polymer layers
PCT/US2005/007164 WO2005084584A1 (en) 2004-03-02 2005-03-02 Medical devices including metallic films and methods for making same
PCT/US2005/006993 WO2006071243A1 (en) 2004-12-29 2005-03-02 Medical devices including metallic films and methods for making same
EP05724762A EP1725188A1 (en) 2004-03-02 2005-03-02 Medical devices including metallic films and methods for making same
PCT/US2005/007162 WO2005084583A2 (en) 2004-03-02 2005-03-02 Medical devices including metallic films and methods for making same
JP2007502033A JP2007526099A (en) 2004-03-02 2005-03-02 MEDICAL DEVICE PROVIDED WITH METAL FILM AND METHOD FOR PRODUCING THE SAME
PCT/US2005/007161 WO2006071244A1 (en) 2004-12-29 2005-03-02 Medical devices including metallic films and methods for making the same
PCT/US2005/007282 WO2005084585A1 (en) 2004-03-02 2005-03-02 Medical devices including metallic films and methods for making same
EP12192288.4A EP2617387A1 (en) 2004-03-02 2005-03-02 Medical devices including metallic films and methods for making same
JP2007502069A JP4712029B2 (en) 2004-03-02 2005-03-02 Medical device including metal film and method for producing the same
PCT/US2005/007173 WO2006071245A1 (en) 2004-12-29 2005-03-02 Medical devices including metallic films and methods for loading and deploying same
CA2558132A CA2558132C (en) 2004-03-02 2005-03-02 Medical devices including metallic films and methods for making same
CA2558131A CA2558131C (en) 2004-03-02 2005-03-02 Medical devices including metallic films and methods for making same
PCT/US2005/006895 WO2006071242A1 (en) 2004-12-29 2005-03-02 Medical devices including metallic films and methods for making same
EP05724667A EP1725187A1 (en) 2004-03-02 2005-03-02 Medical devices including metallic films and methods for making same
US13/031,923 US8864815B2 (en) 2004-12-29 2011-02-22 Medical devices including metallic film and at least one filament
US14/519,685 US9833310B2 (en) 2004-12-29 2014-10-21 Medical devices including metallic film and at least one filament

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/025,684 US7901447B2 (en) 2004-12-29 2004-12-29 Medical devices including a metallic film and at least one filament

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/031,923 Continuation US8864815B2 (en) 2004-12-29 2011-02-22 Medical devices including metallic film and at least one filament

Publications (2)

Publication Number Publication Date
US20060142842A1 true US20060142842A1 (en) 2006-06-29
US7901447B2 US7901447B2 (en) 2011-03-08

Family

ID=36612810

Family Applications (3)

Application Number Title Priority Date Filing Date
US11/025,684 Active 2026-06-17 US7901447B2 (en) 2004-03-02 2004-12-29 Medical devices including a metallic film and at least one filament
US13/031,923 Active 2027-06-04 US8864815B2 (en) 2004-12-29 2011-02-22 Medical devices including metallic film and at least one filament
US14/519,685 Active 2025-09-12 US9833310B2 (en) 2004-12-29 2014-10-21 Medical devices including metallic film and at least one filament

Family Applications After (2)

Application Number Title Priority Date Filing Date
US13/031,923 Active 2027-06-04 US8864815B2 (en) 2004-12-29 2011-02-22 Medical devices including metallic film and at least one filament
US14/519,685 Active 2025-09-12 US9833310B2 (en) 2004-12-29 2014-10-21 Medical devices including metallic film and at least one filament

Country Status (1)

Country Link
US (3) US7901447B2 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050197690A1 (en) * 2004-03-02 2005-09-08 Masoud Molaei Medical devices including metallic films and methods for making same
US20050197689A1 (en) * 2004-03-02 2005-09-08 Masoud Molaei Medical devices including metallic films and methods for making same
US20050197687A1 (en) * 2004-03-02 2005-09-08 Masoud Molaei Medical devices including metallic films and methods for making same
US20060142845A1 (en) * 2004-12-29 2006-06-29 Masoud Molaei Medical devices including metallic films and methods for making same
US20060142851A1 (en) * 2004-12-29 2006-06-29 Masoud Molaei Medical devices including metallic films and methods for making same
US20060259131A1 (en) * 2005-05-16 2006-11-16 Masoud Molaei Medical devices including metallic films and methods for making same
US7901447B2 (en) * 2004-12-29 2011-03-08 Boston Scientific Scimed, Inc. Medical devices including a metallic film and at least one filament
US20110213412A1 (en) * 2010-02-26 2011-09-01 ProMed, Inc. Apparatus for vessel access closure
US20160158039A1 (en) * 2013-05-03 2016-06-09 Acandis Gmbh & Co. Kg Medical device for inserting into a hollow organ of the body

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8458879B2 (en) * 2001-07-03 2013-06-11 Advanced Bio Prosthetic Surfaces, Ltd., A Wholly Owned Subsidiary Of Palmaz Scientific, Inc. Method of fabricating an implantable medical device
KR101300437B1 (en) 2004-05-25 2013-08-26 코비디엔 엘피 Vascular stenting for aneurysms
US20060206200A1 (en) 2004-05-25 2006-09-14 Chestnut Medical Technologies, Inc. Flexible vascular occluding device
AU2005247490B2 (en) 2004-05-25 2011-05-19 Covidien Lp Flexible vascular occluding device
US8628564B2 (en) 2004-05-25 2014-01-14 Covidien Lp Methods and apparatus for luminal stenting
US8152833B2 (en) 2006-02-22 2012-04-10 Tyco Healthcare Group Lp Embolic protection systems having radiopaque filter mesh
US10716573B2 (en) 2008-05-01 2020-07-21 Aneuclose Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm
US10028747B2 (en) 2008-05-01 2018-07-24 Aneuclose Llc Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm
US20110004294A1 (en) * 2009-07-02 2011-01-06 Abbott Laboratories Fatigue-resistant stent
US9358140B1 (en) 2009-11-18 2016-06-07 Aneuclose Llc Stent with outer member to embolize an aneurysm
US8636811B2 (en) * 2010-04-07 2014-01-28 Medtronic Vascular, Inc. Drug eluting rolled stent and stent delivery system
US9301831B2 (en) 2012-10-30 2016-04-05 Covidien Lp Methods for attaining a predetermined porosity of a vascular device
US9452070B2 (en) 2012-10-31 2016-09-27 Covidien Lp Methods and systems for increasing a density of a region of a vascular device
US9943427B2 (en) 2012-11-06 2018-04-17 Covidien Lp Shaped occluding devices and methods of using the same
US9157174B2 (en) 2013-02-05 2015-10-13 Covidien Lp Vascular device for aneurysm treatment and providing blood flow into a perforator vessel
IL246009B (en) * 2016-06-02 2018-11-29 Ezer Haim Method and system for monitoring condition of cerebral aneurysms

Citations (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5035706A (en) * 1989-10-17 1991-07-30 Cook Incorporated Percutaneous stent and method for retrieval thereof
US5085535A (en) * 1991-04-12 1992-02-04 Solberg Joseph R Locating mechanism
US5119555A (en) * 1988-09-19 1992-06-09 Tini Alloy Company Non-explosive separation device
US5302261A (en) * 1991-03-18 1994-04-12 Noranda Inc. Power assisted dezincing of galvanized steel
US5306294A (en) * 1992-08-05 1994-04-26 Ultrasonic Sensing And Monitoring Systems, Inc. Stent construction of rolled configuration
US5325880A (en) * 1993-04-19 1994-07-05 Tini Alloy Company Shape memory alloy film actuated microvalve
US5382261A (en) * 1992-09-01 1995-01-17 Expandable Grafts Partnership Method and apparatus for occluding vessels
US5405378A (en) * 1992-05-20 1995-04-11 Strecker; Ernst P. Device with a prosthesis implantable in the body of a patient
US5441515A (en) * 1993-04-23 1995-08-15 Advanced Cardiovascular Systems, Inc. Ratcheting stent
US5518680A (en) * 1993-10-18 1996-05-21 Massachusetts Institute Of Technology Tissue regeneration matrices by solid free form fabrication techniques
US5607466A (en) * 1992-02-03 1997-03-04 Schneider (Europe) A.G. Catheter with a stent
US5619177A (en) * 1995-01-27 1997-04-08 Mjb Company Shape memory alloy microactuator having an electrostatic force and heating means
US5728150A (en) * 1996-07-29 1998-03-17 Cardiovascular Dynamics, Inc. Expandable microporous prosthesis
US5755734A (en) * 1996-05-03 1998-05-26 Medinol Ltd. Bifurcated stent and method of making same
US5860998A (en) * 1996-11-25 1999-01-19 C. R. Bard, Inc. Deployment device for tubular expandable prosthesis
US5865723A (en) * 1995-12-29 1999-02-02 Ramus Medical Technologies Method and apparatus for forming vascular prostheses
US5882444A (en) * 1995-05-02 1999-03-16 Litana Ltd. Manufacture of two-way shape memory devices
US5888734A (en) * 1992-05-22 1999-03-30 Cremer; Christoph Method for preparing and hybridizing specific probes
US5897911A (en) * 1997-08-11 1999-04-27 Advanced Cardiovascular Systems, Inc. Polymer-coated stent structure
US5903099A (en) * 1997-05-23 1999-05-11 Tini Alloy Company Fabrication system, method and apparatus for microelectromechanical devices
US5938697A (en) * 1998-03-04 1999-08-17 Scimed Life Systems, Inc. Stent having variable properties
US5941249A (en) * 1996-09-05 1999-08-24 Maynard; Ronald S. Distributed activator for a two-dimensional shape memory alloy
US6015431A (en) * 1996-12-23 2000-01-18 Prograft Medical, Inc. Endolumenal stent-graft with leak-resistant seal
US6015433A (en) * 1998-05-29 2000-01-18 Micro Therapeutics, Inc. Rolled stent with waveform perforation pattern
US6017977A (en) * 1996-01-31 2000-01-25 Micro Therapeutics, Inc. Methods for embolizing blood vessels
US6036725A (en) * 1998-06-10 2000-03-14 General Science And Technology Expandable endovascular support device
US6043451A (en) * 1997-11-06 2000-03-28 Promet Technologies, Inc. Plasma spraying of nickel-titanium compound
US6048622A (en) * 1994-04-19 2000-04-11 Massachusetts Institute Of Technology Composites for structural control
US6059766A (en) * 1998-02-27 2000-05-09 Micro Therapeutics, Inc. Gynecologic embolotherapy methods
US6077298A (en) * 1999-02-20 2000-06-20 Tu; Lily Chen Expandable/retractable stent and methods thereof
US6096175A (en) * 1998-07-17 2000-08-01 Micro Therapeutics, Inc. Thin film stent
US6107004A (en) * 1991-09-05 2000-08-22 Intra Therapeutics, Inc. Method for making a tubular stent for use in medical applications
US6190404B1 (en) * 1997-11-07 2001-02-20 Advanced Bio Prosthetic Surfaces, Ltd. Intravascular stent and method for manufacturing an intravascular stent
US6206911B1 (en) * 1996-12-19 2001-03-27 Simcha Milo Stent combination
US6224630B1 (en) * 1998-05-29 2001-05-01 Advanced Bio Surfaces, Inc. Implantable tissue repair device
US6224627B1 (en) * 1998-06-15 2001-05-01 Gore Enterprise Holdings, Inc. Remotely removable covering and support
US20010001834A1 (en) * 1999-11-19 2001-05-24 Palmaz Julio C. Endoluminal device exhibiting improved endothelialization and method of manufacture thereof
US6245104B1 (en) * 1999-02-28 2001-06-12 Inflow Dynamics Inc. Method of fabricating a biocompatible stent
US6254628B1 (en) * 1996-12-09 2001-07-03 Micro Therapeutics, Inc. Intracranial stent
US6258117B1 (en) * 1999-04-15 2001-07-10 Mayo Foundation For Medical Education And Research Multi-section stent
US20020007958A1 (en) * 2000-06-13 2002-01-24 Patrick Rivelli Fatigue-resistant conductive wire article
US20020017503A1 (en) * 2000-05-19 2002-02-14 Banas Christopher E. Methods and apparatus for manufacturing an intravascular stent
US20020019662A1 (en) * 2000-06-05 2002-02-14 Brauckman Richard A. Device for delivering a radioactive and/or drug dosage alone or in connection with a vascular stent
US6355055B1 (en) * 1995-09-01 2002-03-12 Emory University Endovascular support device and method of use
US20020035774A1 (en) * 1999-09-22 2002-03-28 Scimed Life Systems, Inc. A Method and Apparatus for Contracting, Loading or Crimping Self-Expanding and Balloon Expandable Stent Devices
US20020042645A1 (en) * 1996-07-03 2002-04-11 Shannon Donald T. Drug eluting radially expandable tubular stented grafts
US20020046783A1 (en) * 2000-07-10 2002-04-25 Johnson A. David Free standing shape memory alloy thin film and method of fabrication
US6398803B1 (en) * 1999-02-02 2002-06-04 Impra, Inc., A Subsidiary Of C.R. Bard, Inc. Partial encapsulation of stents
US6406487B2 (en) * 1997-05-02 2002-06-18 Micro Therapeutics, Inc. Expandable stent apparatus and method
US6428569B1 (en) * 1999-11-09 2002-08-06 Scimed Life Systems Inc. Micro structure stent configurations
US20030004567A1 (en) * 2000-11-07 2003-01-02 Boyle Christopher T. Endoluminal stent, self-supporting endoluminal graft and methods of making same
US20030002994A1 (en) * 2001-03-07 2003-01-02 Johnson A. David Thin film shape memory alloy actuated flow controller
US6506211B1 (en) * 2000-11-13 2003-01-14 Scimed Life Systems, Inc. Stent designs
US20030018354A1 (en) * 2001-07-18 2003-01-23 Roth Noah M. Integral vascular filter system with core wire activation
US20030023303A1 (en) * 1999-11-19 2003-01-30 Palmaz Julio C. Valvular prostheses having metal or pseudometallic construction and methods of manufacture
US6520984B1 (en) * 2000-04-28 2003-02-18 Cardiovasc, Inc. Stent graft assembly and method
US20030040791A1 (en) * 2001-08-22 2003-02-27 Oktay Hasan Semih Flexible MEMS actuated controlled expansion stent
US20030050691A1 (en) * 2000-02-09 2003-03-13 Edward Shifrin Non-thrombogenic implantable devices
US6533905B2 (en) * 2000-01-24 2003-03-18 Tini Alloy Company Method for sputtering tini shape-memory alloys
US6537310B1 (en) * 1999-11-19 2003-03-25 Advanced Bio Prosthetic Surfaces, Ltd. Endoluminal implantable devices and method of making same
US20030060782A1 (en) * 1998-06-04 2003-03-27 Arani Bose Endovascular thin film devices and methods for treating and preventing stroke
US20030059640A1 (en) * 1999-11-19 2003-03-27 Denes Marton High strength vacuum deposited nitinol alloy films and method of making same
US20030074049A1 (en) * 2000-08-25 2003-04-17 Kensey Nash Corporation Covered stents and systems for deploying covered stents
US20030083731A1 (en) * 2001-10-25 2003-05-01 Kramer Pamela A. Manufacture of fine-grained material for use in medical devices
US20030130721A1 (en) * 1995-12-14 2003-07-10 Martin Gerald Ray Kink resistant stent-graft
US20030139797A1 (en) * 2002-01-24 2003-07-24 Kirk Johnson Covered segmented stent
US20030153971A1 (en) * 2002-02-14 2003-08-14 Chandru Chandrasekaran Metal reinforced biodegradable intraluminal stents
US6673102B1 (en) * 1999-01-22 2004-01-06 Gore Enterprises Holdings, Inc. Covered endoprosthesis and delivery system
US20040014253A1 (en) * 2002-07-17 2004-01-22 Vikas Gupta Three dimensional thin film devices and methods of fabrication
US20040034408A1 (en) * 2002-05-10 2004-02-19 Majercak David Christopher Method of placing a tubular membrane on a structural frame
US6695865B2 (en) * 2000-03-20 2004-02-24 Advanced Bio Prosthetic Surfaces, Ltd. Embolic protection device
US6699279B2 (en) * 1998-04-30 2004-03-02 The Board Of Trustees Of The Leland Stanford Junior University Expandable space frame
US6699278B2 (en) * 2000-09-22 2004-03-02 Cordis Corporation Stent with optimal strength and radiopacity characteristics
US20040054406A1 (en) * 2000-12-19 2004-03-18 Alexander Dubson Vascular prosthesis and method for production thereof
US20040054399A1 (en) * 2002-09-17 2004-03-18 Roth Noah M. Anti-galvanic stent coating
US20040059410A1 (en) * 2000-11-14 2004-03-25 Cox Daniel L. Austenitic nitinol medical devices
US20040107004A1 (en) * 2002-12-02 2004-06-03 Seedling Enterprises, Llc Bariatric sleeve
US6746478B2 (en) * 1999-11-16 2004-06-08 Vascular Concepts Holdings Limited Stent formed from encapsulated stent preforms
US6767418B1 (en) * 1999-04-23 2004-07-27 Terumo Kabushiki Kaisha Ti-Zr type alloy and medical appliance formed thereof
US20050010275A1 (en) * 2002-10-11 2005-01-13 Sahatjian Ronald A. Implantable medical devices
US6849085B2 (en) * 1999-11-19 2005-02-01 Advanced Bio Prosthetic Surfaces, Ltd. Self-supporting laminated films, structural materials and medical devices manufactured therefrom and method of making same
US20050165468A1 (en) * 2000-05-12 2005-07-28 Denes Marton Self-supporting laminated films, structural materials and medical devices manufactured therefrom and methods of making same
US20060115514A1 (en) * 2004-11-26 2006-06-01 Stela Gengrinovitch Chelating and binding chemicals to a medical implant, medical device formed, and therapeutic applications
US20060142838A1 (en) * 2004-12-29 2006-06-29 Masoud Molaei Medical devices including metallic films and methods for loading and deploying same
US20060142845A1 (en) * 2004-12-29 2006-06-29 Masoud Molaei Medical devices including metallic films and methods for making same
US20060142851A1 (en) * 2004-12-29 2006-06-29 Masoud Molaei Medical devices including metallic films and methods for making same
US20060147492A1 (en) * 2003-11-10 2006-07-06 Angiotech International Ag Medical implants and anti-scarring agents
US20070073385A1 (en) * 2005-09-20 2007-03-29 Cook Incorporated Eluting, implantable medical device
US20080027388A1 (en) * 1999-11-19 2008-01-31 Advanced Bio Prosthetic Surfaces, Ltd. Guidewires and thin film catheter-sheaths and method of making same
US20090187240A1 (en) * 2008-01-17 2009-07-23 Boston Scientific Scimed, Inc. Stent with anti-migration feature
US20100030320A1 (en) * 2004-09-28 2010-02-04 Feller Iii Frederick Thin film medical device and delivery system

Family Cites Families (125)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2125442B (en) 1982-05-24 1986-02-19 Atomic Energy Authority Uk A procedure for the hardening of materials
US4793348A (en) 1986-11-15 1988-12-27 Palmaz Julio C Balloon expandable vena cava filter to prevent migration of lower extremity venous clots into the pulmonary circulation
US5245738A (en) 1988-09-19 1993-09-21 Tini Alloy Company Method for securing together and non-explosively separating multiple components
US4864824A (en) 1988-10-31 1989-09-12 American Telephone And Telegraph Company, At&T Bell Laboratories Thin film shape memory alloy and method for producing
US5061914A (en) 1989-06-27 1991-10-29 Tini Alloy Company Shape-memory alloy micro-actuator
JPH067843B2 (en) 1990-02-15 1994-02-02 寛治 井上 Artificial blood vessel with frame
US5571166A (en) * 1992-03-19 1996-11-05 Medtronic, Inc. Method of making an intraluminal stent
US5817102A (en) 1992-05-08 1998-10-06 Schneider (Usa) Inc. Apparatus for delivering and deploying a stent
WO1994021196A2 (en) 1993-03-18 1994-09-29 C.R. Bard, Inc. Endovascular stents
US6315788B1 (en) 1994-02-10 2001-11-13 United States Surgical Corporation Composite materials and surgical articles made therefrom
US5556413A (en) 1994-03-11 1996-09-17 Advanced Cardiovascular Systems, Inc. Coiled stent with locking ends
EP0792627B2 (en) 1994-06-08 2003-10-29 Cardiovascular Concepts, Inc. System for forming a bifurcated graft
DE4429380C1 (en) 1994-08-15 1996-04-25 Biotronik Mess & Therapieg Method for producing a non-collapsing intravascular vascular prosthesis (stent)
CA2175377A1 (en) 1994-08-29 1996-03-07 Jainagesh A. Sekhar Filter manufactured by micropyrectic synthesis
AU3783195A (en) 1994-11-15 1996-05-23 Advanced Cardiovascular Systems Inc. Intraluminal stent for attaching a graft
US5667523A (en) 1995-04-28 1997-09-16 Impra, Inc. Dual supported intraluminal graft
US5674242A (en) 1995-06-06 1997-10-07 Quanam Medical Corporation Endoprosthetic device with therapeutic compound
AU716005B2 (en) 1995-06-07 2000-02-17 Cook Medical Technologies Llc Implantable medical device
US6348066B1 (en) 1995-11-07 2002-02-19 Corvita Corporation Modular endoluminal stent-grafts and methods for their use
US5843158A (en) 1996-01-05 1998-12-01 Medtronic, Inc. Limited expansion endoluminal prostheses and methods for their use
US5843289A (en) 1996-01-22 1998-12-01 Etex Corporation Surface modification of medical implants
US5824042A (en) 1996-04-05 1998-10-20 Medtronic, Inc. Endoluminal prostheses having position indicating markers
US5843163A (en) * 1996-06-06 1998-12-01 Wall; William H. Expandable stent having radioactive treatment means
US8728143B2 (en) 1996-06-06 2014-05-20 Biosensors International Group, Ltd. Endoprosthesis deployment system for treating vascular bifurcations
US5676697A (en) 1996-07-29 1997-10-14 Cardiovascular Dynamics, Inc. Two-piece, bifurcated intraluminal graft for repair of aneurysm
US6120535A (en) 1996-07-29 2000-09-19 Radiance Medical Systems, Inc. Microporous tubular prosthesis
US5800517A (en) 1996-08-19 1998-09-01 Scimed Life Systems, Inc. Stent delivery system with storage sleeve
US6133547A (en) 1996-09-05 2000-10-17 Medtronic, Inc. Distributed activator for a two-dimensional shape memory alloy
US6007573A (en) 1996-09-18 1999-12-28 Microtherapeutics, Inc. Intracranial stent and method of use
US6099561A (en) 1996-10-21 2000-08-08 Inflow Dynamics, Inc. Vascular and endoluminal stents with improved coatings
US6048360A (en) 1997-03-18 2000-04-11 Endotex Interventional Systems, Inc. Methods of making and using coiled sheet graft for single and bifurcated lumens
US5824054A (en) 1997-03-18 1998-10-20 Endotex Interventional Systems, Inc. Coiled sheet graft stent and methods of making and use
US5951599A (en) 1997-07-09 1999-09-14 Scimed Life Systems, Inc. Occlusion system for endovascular treatment of an aneurysm
US6174330B1 (en) 1997-08-01 2001-01-16 Schneider (Usa) Inc Bioabsorbable marker having radiopaque constituents
US6769161B2 (en) 1997-10-16 2004-08-03 Scimed Life Systems, Inc. Radial stent crimper
NO311781B1 (en) 1997-11-13 2002-01-28 Medinol Ltd Metal multilayer stents
US6626939B1 (en) 1997-12-18 2003-09-30 Boston Scientific Scimed, Inc. Stent-graft with bioabsorbable structural support
US6132460A (en) 1998-03-27 2000-10-17 Intratherapeutics, Inc. Stent
US7179289B2 (en) 1998-03-30 2007-02-20 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US6447478B1 (en) 1998-05-15 2002-09-10 Ronald S. Maynard Thin-film shape memory alloy actuators and processing methods
US6139564A (en) 1998-06-16 2000-10-31 Target Therapeutics Inc. Minimally occlusive flow disruptor stent for bridging aneurysm necks
US6159239A (en) 1998-08-14 2000-12-12 Prodesco, Inc. Woven stent/graft structure
US6312461B1 (en) 1998-08-21 2001-11-06 John D. Unsworth Shape memory tubular stent
US6143022A (en) 1998-08-24 2000-11-07 Medtronic Ave, Inc. Stent-graft assembly with dual configuration graft component and method of manufacture
US6458092B1 (en) * 1998-09-30 2002-10-01 C. R. Bard, Inc. Vascular inducing implants
WO2000019942A1 (en) 1998-10-04 2000-04-13 Brainwave Cardio-Vascular Technologies Ltd. Flexible expandable sheet stent and technology of its manufacturing
US6325820B1 (en) 1998-11-16 2001-12-04 Endotex Interventional Systems, Inc. Coiled-sheet stent-graft with exo-skeleton
US20060122691A1 (en) 1998-12-03 2006-06-08 Jacob Richter Hybrid stent
US20050033399A1 (en) 1998-12-03 2005-02-10 Jacob Richter Hybrid stent
US6620192B1 (en) 1999-03-16 2003-09-16 Advanced Cardiovascular Systems, Inc. Multilayer stent
US6303100B1 (en) 1999-03-19 2001-10-16 Micro Therapeutics, Inc. Methods for inhibiting the formation of potential endoleaks associated with endovascular repair of abdominal aortic aneurysms
CA2370180C (en) 1999-04-15 2009-07-07 Smart Therapeutics, Inc. Intravascular stent and method of treating neurovascular vessel lesion
AU5144600A (en) 1999-05-21 2000-12-12 Micro Therapeutics, Inc. Methods for embolizing vascular sites with an embolizing composition
US20020173809A1 (en) 1999-09-01 2002-11-21 Fleischman Sidney D. Sutureless anastomosis system deployment concepts
US6733513B2 (en) 1999-11-04 2004-05-11 Advanced Bioprosthetic Surfaces, Ltd. Balloon catheter having metal balloon and method of making same
US6936066B2 (en) 1999-11-19 2005-08-30 Advanced Bio Prosthetic Surfaces, Ltd. Complaint implantable medical devices and methods of making same
US6458153B1 (en) 1999-12-31 2002-10-01 Abps Venture One, Ltd. Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof
US20060052865A1 (en) * 2004-09-09 2006-03-09 Banas Christopher E Stents with metallic covers and methods of making same
US10172730B2 (en) 1999-11-19 2019-01-08 Vactronix Scientific, Llc Stents with metallic covers and methods of making same
US7300457B2 (en) 1999-11-19 2007-11-27 Advanced Bio Prosthetic Surfaces, Ltd. Self-supporting metallic implantable grafts, compliant implantable medical devices and methods of making same
US6471721B1 (en) 1999-12-30 2002-10-29 Advanced Cardiovascular Systems, Inc. Vascular stent having increased radiopacity and method for making same
US6624730B2 (en) 2000-03-28 2003-09-23 Tini Alloy Company Thin film shape memory alloy actuated microrelay
US7867186B2 (en) * 2002-04-08 2011-01-11 Glaukos Corporation Devices and methods for treatment of ocular disorders
AU2001261455B2 (en) 2000-05-12 2007-01-25 Vactronix Scientific, Llc Self-supporting laminated films, structural materials and medical devices
US8252044B1 (en) 2000-11-17 2012-08-28 Advanced Bio Prosthestic Surfaces, Ltd. Device for in vivo delivery of bioactive agents and method of manufacture thereof
DE10026485A1 (en) 2000-05-29 2001-12-13 Udo Heinrich Grabowy System with a carrier substrate with a Ti / P or AI / P coating
US7632303B1 (en) * 2000-06-07 2009-12-15 Advanced Cardiovascular Systems, Inc. Variable stiffness medical devices
US20030050684A1 (en) * 2001-09-10 2003-03-13 Abrams Robert M. Internal restraint for delivery of self-expanding stents
US6953560B1 (en) 2000-09-28 2005-10-11 Advanced Cardiovascular Systems, Inc. Barriers for polymer-coated implantable medical devices and methods for making the same
US6614570B2 (en) 2000-09-29 2003-09-02 Tini Alloy Company Shutter for fiber optic systems
US7037330B1 (en) 2000-10-16 2006-05-02 Scimed Life Systems, Inc. Neurovascular stent and method
FR2816201B1 (en) 2000-11-07 2003-08-01 Medicrea INTERVERTEBRAL CAGE AND INSTRUMENT FOR PLACING THIS CAGE BETWEEN TWO VERTEBRES
US6618921B1 (en) 2000-11-16 2003-09-16 Scimed Life Systems, Inc. Bare stent ship and crimp device
US20040030377A1 (en) 2001-10-19 2004-02-12 Alexander Dubson Medicated polymer-coated stent assembly
US6471980B2 (en) 2000-12-22 2002-10-29 Avantec Vascular Corporation Intravascular delivery of mycophenolic acid
US6569194B1 (en) 2000-12-28 2003-05-27 Advanced Cardiovascular Systems, Inc. Thermoelastic and superelastic Ni-Ti-W alloy
US20020162605A1 (en) 2001-03-05 2002-11-07 Horton Joseph A. Bulk metallic glass medical instruments, implants, and methods of using same
US7294137B2 (en) 2001-03-27 2007-11-13 Boston Scientific Scimed Device for multi-modal treatment of vascular lesions
US6872433B2 (en) 2001-03-27 2005-03-29 The Regents Of The University Of California Shape memory alloy/shape memory polymer tools
US20020187288A1 (en) 2001-06-11 2002-12-12 Advanced Cardiovascular Systems, Inc. Medical device formed of silicone-polyurethane
US6729599B2 (en) 2001-06-26 2004-05-04 Tini Alloy Company Liquid microvalve
US6676987B2 (en) 2001-07-02 2004-01-13 Scimed Life Systems, Inc. Coating a medical appliance with a bubble jet printing head
IN2014DN10834A (en) 2001-09-17 2015-09-04 Psivida Inc
JP2003102849A (en) 2001-09-28 2003-04-08 Terumo Corp Stent indwelling in living body
US6752826B2 (en) 2001-12-14 2004-06-22 Thoratec Corporation Layered stent-graft and methods of making the same
US6669795B2 (en) 2002-01-17 2003-12-30 Tini Alloy Company Methods of fabricating high transition temperature SMA, and SMA materials made by the methods
US6620634B2 (en) 2002-01-17 2003-09-16 Tini Alloy Company Method of accurately measuring compositions of thin film shape memory alloys
US7708771B2 (en) 2002-02-26 2010-05-04 Endovascular Technologies, Inc. Endovascular graft device and methods for attaching components thereof
US7063707B2 (en) 2002-03-06 2006-06-20 Scimed Life Systems, Inc. Medical retrieval device
US7462366B2 (en) 2002-03-29 2008-12-09 Boston Scientific Scimed, Inc. Drug delivery particle
US20030187495A1 (en) 2002-04-01 2003-10-02 Cully Edward H. Endoluminal devices, embolic filters, methods of manufacture and use
US7887575B2 (en) 2002-05-22 2011-02-15 Boston Scientific Scimed, Inc. Stent with segmented graft
ATE533433T1 (en) * 2002-06-26 2011-12-15 Cook Medical Technologies Llc STENT-GRAFT ATTACHMENT
US7232459B2 (en) 2002-06-28 2007-06-19 Cook Incorporated Thoracic aortic aneurysm stent graft
AU2003270817B2 (en) 2002-09-26 2009-09-17 Vactronix Scientific, Llc High strength vacuum deposited nitionol alloy films, medical thin film graft materials and method of making same
US6638301B1 (en) 2002-10-02 2003-10-28 Scimed Life Systems, Inc. Medical device with radiopacity
US20040093017A1 (en) * 2002-11-06 2004-05-13 Nmt Medical, Inc. Medical devices utilizing modified shape memory alloy
US20050165469A1 (en) 2002-12-24 2005-07-28 Michael Hogendijk Vascular prosthesis including torsional stabilizer and methods of use
US7105018B1 (en) 2002-12-30 2006-09-12 Advanced Cardiovascular Systems, Inc. Drug-eluting stent cover and method of use
US20040143317A1 (en) 2003-01-17 2004-07-22 Stinson Jonathan S. Medical devices
US7096554B2 (en) 2003-04-04 2006-08-29 Boston Scientific Scimed, Inc. Protective loading of stents
US8021418B2 (en) 2003-06-19 2011-09-20 Boston Scientific Scimed, Inc. Sandwiched radiopaque marker on covered stent
WO2005015923A1 (en) 2003-08-08 2005-02-17 Slieve Mish Inventions Limited Terminal adapter for associating user components and emulating a network entity
AU2005212334B2 (en) 2004-02-09 2011-06-16 Cook Medical Technologies Llc Stent graft devices having collagen coating
EP2614793A1 (en) 2004-03-02 2013-07-17 Boston Scientific Scimed, Inc. Medical devices including metallic films and methods for making same
US8591568B2 (en) * 2004-03-02 2013-11-26 Boston Scientific Scimed, Inc. Medical devices including metallic films and methods for making same
US7901447B2 (en) * 2004-12-29 2011-03-08 Boston Scientific Scimed, Inc. Medical devices including a metallic film and at least one filament
US8998973B2 (en) * 2004-03-02 2015-04-07 Boston Scientific Scimed, Inc. Medical devices including metallic films
US20050197687A1 (en) * 2004-03-02 2005-09-08 Masoud Molaei Medical devices including metallic films and methods for making same
EP1604697A1 (en) 2004-06-09 2005-12-14 J.A.C.C. GmbH Implantable device
WO2006033958A1 (en) 2004-09-17 2006-03-30 Nitinol Development Corporation Shape memory thin film embolic protection device
JP2008513155A (en) 2004-09-20 2008-05-01 コーディス・コーポレイション Thin film medical devices and delivery systems
US7410497B2 (en) * 2004-12-14 2008-08-12 Boston Scientific Scimed, Inc. Stimulation of cell growth at implant surfaces
EP2314165B1 (en) 2004-12-23 2014-10-01 Albemarle Corporation Microbiocidal control in the processing of meat-producing four-legged animals
WO2006071243A1 (en) 2004-12-29 2006-07-06 Boston Scientific Limited Medical devices including metallic films and methods for making same
WO2006071244A1 (en) 2004-12-29 2006-07-06 Boston Scientific Limited Medical devices including metallic films and methods for making the same
WO2006071245A1 (en) 2004-12-29 2006-07-06 Boston Scientific Limited Medical devices including metallic films and methods for loading and deploying same
WO2006071242A1 (en) 2004-12-29 2006-07-06 Boston Scientific Limited Medical devices including metallic films and methods for making same
WO2006086304A1 (en) * 2005-02-08 2006-08-17 Wilson-Cook Medical Inc. Self contracting stent
US7854760B2 (en) 2005-05-16 2010-12-21 Boston Scientific Scimed, Inc. Medical devices including metallic films
US20060271158A1 (en) 2005-05-26 2006-11-30 Boston Scientific Scimed, Inc. Positional locking endoluminal device system
US20070016283A1 (en) 2005-06-28 2007-01-18 Stout Medical Group, Inc. Micro-thin film structures for cardiovascular indications
US9017395B2 (en) 2007-03-09 2015-04-28 Novostent Corporation Vascular prosthesis and methods of use
CN102245127B (en) 2008-10-10 2014-06-11 雷瓦医药公司 Expandable slide and lock stent
US8425586B2 (en) 2009-09-02 2013-04-23 Novostent Corporation Vascular prosthesis with stress relief slots

Patent Citations (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5119555A (en) * 1988-09-19 1992-06-09 Tini Alloy Company Non-explosive separation device
US5035706A (en) * 1989-10-17 1991-07-30 Cook Incorporated Percutaneous stent and method for retrieval thereof
US5302261A (en) * 1991-03-18 1994-04-12 Noranda Inc. Power assisted dezincing of galvanized steel
US5085535A (en) * 1991-04-12 1992-02-04 Solberg Joseph R Locating mechanism
US6107004A (en) * 1991-09-05 2000-08-22 Intra Therapeutics, Inc. Method for making a tubular stent for use in medical applications
US5607466A (en) * 1992-02-03 1997-03-04 Schneider (Europe) A.G. Catheter with a stent
US5405378A (en) * 1992-05-20 1995-04-11 Strecker; Ernst P. Device with a prosthesis implantable in the body of a patient
US5888734A (en) * 1992-05-22 1999-03-30 Cremer; Christoph Method for preparing and hybridizing specific probes
US5306294A (en) * 1992-08-05 1994-04-26 Ultrasonic Sensing And Monitoring Systems, Inc. Stent construction of rolled configuration
US5656036A (en) * 1992-09-01 1997-08-12 Expandable Grafts Partnership Apparatus for occluding vessels
US5382261A (en) * 1992-09-01 1995-01-17 Expandable Grafts Partnership Method and apparatus for occluding vessels
US5325880A (en) * 1993-04-19 1994-07-05 Tini Alloy Company Shape memory alloy film actuated microvalve
US5441515A (en) * 1993-04-23 1995-08-15 Advanced Cardiovascular Systems, Inc. Ratcheting stent
US5518680A (en) * 1993-10-18 1996-05-21 Massachusetts Institute Of Technology Tissue regeneration matrices by solid free form fabrication techniques
US6048622A (en) * 1994-04-19 2000-04-11 Massachusetts Institute Of Technology Composites for structural control
US5619177A (en) * 1995-01-27 1997-04-08 Mjb Company Shape memory alloy microactuator having an electrostatic force and heating means
US5882444A (en) * 1995-05-02 1999-03-16 Litana Ltd. Manufacture of two-way shape memory devices
US6355055B1 (en) * 1995-09-01 2002-03-12 Emory University Endovascular support device and method of use
US20030130721A1 (en) * 1995-12-14 2003-07-10 Martin Gerald Ray Kink resistant stent-graft
US5865723A (en) * 1995-12-29 1999-02-02 Ramus Medical Technologies Method and apparatus for forming vascular prostheses
US6017977A (en) * 1996-01-31 2000-01-25 Micro Therapeutics, Inc. Methods for embolizing blood vessels
US5755734A (en) * 1996-05-03 1998-05-26 Medinol Ltd. Bifurcated stent and method of making same
US20020042645A1 (en) * 1996-07-03 2002-04-11 Shannon Donald T. Drug eluting radially expandable tubular stented grafts
US5728150A (en) * 1996-07-29 1998-03-17 Cardiovascular Dynamics, Inc. Expandable microporous prosthesis
US5941249A (en) * 1996-09-05 1999-08-24 Maynard; Ronald S. Distributed activator for a two-dimensional shape memory alloy
US6409749B1 (en) * 1996-09-05 2002-06-25 Ronald S. Maynard Aneurism patch including distributed activator for a two-dimensional shape memory alloy
US5860998A (en) * 1996-11-25 1999-01-19 C. R. Bard, Inc. Deployment device for tubular expandable prosthesis
US6254628B1 (en) * 1996-12-09 2001-07-03 Micro Therapeutics, Inc. Intracranial stent
US6206911B1 (en) * 1996-12-19 2001-03-27 Simcha Milo Stent combination
US6015431A (en) * 1996-12-23 2000-01-18 Prograft Medical, Inc. Endolumenal stent-graft with leak-resistant seal
US6406487B2 (en) * 1997-05-02 2002-06-18 Micro Therapeutics, Inc. Expandable stent apparatus and method
US5903099A (en) * 1997-05-23 1999-05-11 Tini Alloy Company Fabrication system, method and apparatus for microelectromechanical devices
US5897911A (en) * 1997-08-11 1999-04-27 Advanced Cardiovascular Systems, Inc. Polymer-coated stent structure
US6043451A (en) * 1997-11-06 2000-03-28 Promet Technologies, Inc. Plasma spraying of nickel-titanium compound
US6190404B1 (en) * 1997-11-07 2001-02-20 Advanced Bio Prosthetic Surfaces, Ltd. Intravascular stent and method for manufacturing an intravascular stent
US6059766A (en) * 1998-02-27 2000-05-09 Micro Therapeutics, Inc. Gynecologic embolotherapy methods
US5938697A (en) * 1998-03-04 1999-08-17 Scimed Life Systems, Inc. Stent having variable properties
US6699279B2 (en) * 1998-04-30 2004-03-02 The Board Of Trustees Of The Leland Stanford Junior University Expandable space frame
US6224630B1 (en) * 1998-05-29 2001-05-01 Advanced Bio Surfaces, Inc. Implantable tissue repair device
US6406490B1 (en) * 1998-05-29 2002-06-18 Micro Therapeutics, Inc. Rolled stent with waveform perforation pattern
US6015433A (en) * 1998-05-29 2000-01-18 Micro Therapeutics, Inc. Rolled stent with waveform perforation pattern
US20030060782A1 (en) * 1998-06-04 2003-03-27 Arani Bose Endovascular thin film devices and methods for treating and preventing stroke
US6036725A (en) * 1998-06-10 2000-03-14 General Science And Technology Expandable endovascular support device
US6224627B1 (en) * 1998-06-15 2001-05-01 Gore Enterprise Holdings, Inc. Remotely removable covering and support
US6096175A (en) * 1998-07-17 2000-08-01 Micro Therapeutics, Inc. Thin film stent
US6527919B1 (en) * 1998-07-17 2003-03-04 Micro Therapeutics, Inc. Thin film stent
US20030159920A1 (en) * 1998-07-17 2003-08-28 Micro Therapeutics, Inc. Thin film stent
US6673102B1 (en) * 1999-01-22 2004-01-06 Gore Enterprises Holdings, Inc. Covered endoprosthesis and delivery system
US6398803B1 (en) * 1999-02-02 2002-06-04 Impra, Inc., A Subsidiary Of C.R. Bard, Inc. Partial encapsulation of stents
US6077298A (en) * 1999-02-20 2000-06-20 Tu; Lily Chen Expandable/retractable stent and methods thereof
US6245104B1 (en) * 1999-02-28 2001-06-12 Inflow Dynamics Inc. Method of fabricating a biocompatible stent
US6258117B1 (en) * 1999-04-15 2001-07-10 Mayo Foundation For Medical Education And Research Multi-section stent
US6767418B1 (en) * 1999-04-23 2004-07-27 Terumo Kabushiki Kaisha Ti-Zr type alloy and medical appliance formed thereof
US20020035774A1 (en) * 1999-09-22 2002-03-28 Scimed Life Systems, Inc. A Method and Apparatus for Contracting, Loading or Crimping Self-Expanding and Balloon Expandable Stent Devices
US6428569B1 (en) * 1999-11-09 2002-08-06 Scimed Life Systems Inc. Micro structure stent configurations
US6746478B2 (en) * 1999-11-16 2004-06-08 Vascular Concepts Holdings Limited Stent formed from encapsulated stent preforms
US6379383B1 (en) * 1999-11-19 2002-04-30 Advanced Bio Prosthetic Surfaces, Ltd. Endoluminal device exhibiting improved endothelialization and method of manufacture thereof
US20030059640A1 (en) * 1999-11-19 2003-03-27 Denes Marton High strength vacuum deposited nitinol alloy films and method of making same
US20030023303A1 (en) * 1999-11-19 2003-01-30 Palmaz Julio C. Valvular prostheses having metal or pseudometallic construction and methods of manufacture
US20080027388A1 (en) * 1999-11-19 2008-01-31 Advanced Bio Prosthetic Surfaces, Ltd. Guidewires and thin film catheter-sheaths and method of making same
US6849085B2 (en) * 1999-11-19 2005-02-01 Advanced Bio Prosthetic Surfaces, Ltd. Self-supporting laminated films, structural materials and medical devices manufactured therefrom and method of making same
US20010001834A1 (en) * 1999-11-19 2001-05-24 Palmaz Julio C. Endoluminal device exhibiting improved endothelialization and method of manufacture thereof
US6537310B1 (en) * 1999-11-19 2003-03-25 Advanced Bio Prosthetic Surfaces, Ltd. Endoluminal implantable devices and method of making same
US6533905B2 (en) * 2000-01-24 2003-03-18 Tini Alloy Company Method for sputtering tini shape-memory alloys
US20030127318A1 (en) * 2000-01-24 2003-07-10 Johnson A. David Method for sputtering TiNi shape-memory alloys
US20030050691A1 (en) * 2000-02-09 2003-03-13 Edward Shifrin Non-thrombogenic implantable devices
US6695865B2 (en) * 2000-03-20 2004-02-24 Advanced Bio Prosthetic Surfaces, Ltd. Embolic protection device
US6520984B1 (en) * 2000-04-28 2003-02-18 Cardiovasc, Inc. Stent graft assembly and method
US20050165468A1 (en) * 2000-05-12 2005-07-28 Denes Marton Self-supporting laminated films, structural materials and medical devices manufactured therefrom and methods of making same
US20020017503A1 (en) * 2000-05-19 2002-02-14 Banas Christopher E. Methods and apparatus for manufacturing an intravascular stent
US20020019662A1 (en) * 2000-06-05 2002-02-14 Brauckman Richard A. Device for delivering a radioactive and/or drug dosage alone or in connection with a vascular stent
US20020007958A1 (en) * 2000-06-13 2002-01-24 Patrick Rivelli Fatigue-resistant conductive wire article
US20020046783A1 (en) * 2000-07-10 2002-04-25 Johnson A. David Free standing shape memory alloy thin film and method of fabrication
US20030074049A1 (en) * 2000-08-25 2003-04-17 Kensey Nash Corporation Covered stents and systems for deploying covered stents
US6699278B2 (en) * 2000-09-22 2004-03-02 Cordis Corporation Stent with optimal strength and radiopacity characteristics
US20030004567A1 (en) * 2000-11-07 2003-01-02 Boyle Christopher T. Endoluminal stent, self-supporting endoluminal graft and methods of making same
US6506211B1 (en) * 2000-11-13 2003-01-14 Scimed Life Systems, Inc. Stent designs
US20040059410A1 (en) * 2000-11-14 2004-03-25 Cox Daniel L. Austenitic nitinol medical devices
US20040054406A1 (en) * 2000-12-19 2004-03-18 Alexander Dubson Vascular prosthesis and method for production thereof
US20030002994A1 (en) * 2001-03-07 2003-01-02 Johnson A. David Thin film shape memory alloy actuated flow controller
US20030018354A1 (en) * 2001-07-18 2003-01-23 Roth Noah M. Integral vascular filter system with core wire activation
US20030040791A1 (en) * 2001-08-22 2003-02-27 Oktay Hasan Semih Flexible MEMS actuated controlled expansion stent
US20030083731A1 (en) * 2001-10-25 2003-05-01 Kramer Pamela A. Manufacture of fine-grained material for use in medical devices
US20030139797A1 (en) * 2002-01-24 2003-07-24 Kirk Johnson Covered segmented stent
US20030153971A1 (en) * 2002-02-14 2003-08-14 Chandru Chandrasekaran Metal reinforced biodegradable intraluminal stents
US20040034408A1 (en) * 2002-05-10 2004-02-19 Majercak David Christopher Method of placing a tubular membrane on a structural frame
US20040014253A1 (en) * 2002-07-17 2004-01-22 Vikas Gupta Three dimensional thin film devices and methods of fabrication
US20040054399A1 (en) * 2002-09-17 2004-03-18 Roth Noah M. Anti-galvanic stent coating
US20050010275A1 (en) * 2002-10-11 2005-01-13 Sahatjian Ronald A. Implantable medical devices
US20040107004A1 (en) * 2002-12-02 2004-06-03 Seedling Enterprises, Llc Bariatric sleeve
US20060147492A1 (en) * 2003-11-10 2006-07-06 Angiotech International Ag Medical implants and anti-scarring agents
US20100030320A1 (en) * 2004-09-28 2010-02-04 Feller Iii Frederick Thin film medical device and delivery system
US20060115514A1 (en) * 2004-11-26 2006-06-01 Stela Gengrinovitch Chelating and binding chemicals to a medical implant, medical device formed, and therapeutic applications
US20060142838A1 (en) * 2004-12-29 2006-06-29 Masoud Molaei Medical devices including metallic films and methods for loading and deploying same
US20060142845A1 (en) * 2004-12-29 2006-06-29 Masoud Molaei Medical devices including metallic films and methods for making same
US20060142851A1 (en) * 2004-12-29 2006-06-29 Masoud Molaei Medical devices including metallic films and methods for making same
US20070073385A1 (en) * 2005-09-20 2007-03-29 Cook Incorporated Eluting, implantable medical device
US20090187240A1 (en) * 2008-01-17 2009-07-23 Boston Scientific Scimed, Inc. Stent with anti-migration feature

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8591568B2 (en) * 2004-03-02 2013-11-26 Boston Scientific Scimed, Inc. Medical devices including metallic films and methods for making same
US20050197689A1 (en) * 2004-03-02 2005-09-08 Masoud Molaei Medical devices including metallic films and methods for making same
US20050197687A1 (en) * 2004-03-02 2005-09-08 Masoud Molaei Medical devices including metallic films and methods for making same
US8998973B2 (en) 2004-03-02 2015-04-07 Boston Scientific Scimed, Inc. Medical devices including metallic films
US20050197690A1 (en) * 2004-03-02 2005-09-08 Masoud Molaei Medical devices including metallic films and methods for making same
US20060142845A1 (en) * 2004-12-29 2006-06-29 Masoud Molaei Medical devices including metallic films and methods for making same
US20060142851A1 (en) * 2004-12-29 2006-06-29 Masoud Molaei Medical devices including metallic films and methods for making same
US8992592B2 (en) 2004-12-29 2015-03-31 Boston Scientific Scimed, Inc. Medical devices including metallic films
US7901447B2 (en) * 2004-12-29 2011-03-08 Boston Scientific Scimed, Inc. Medical devices including a metallic film and at least one filament
US20110144740A1 (en) * 2004-12-29 2011-06-16 Boston Scientific Scimed, Inc. Medical Devices Including Metallic Film and at Least One Filament
US8864815B2 (en) * 2004-12-29 2014-10-21 Boston Scientific Scimed, Inc. Medical devices including metallic film and at least one filament
US8632580B2 (en) 2004-12-29 2014-01-21 Boston Scientific Scimed, Inc. Flexible medical devices including metallic films
US7854760B2 (en) 2005-05-16 2010-12-21 Boston Scientific Scimed, Inc. Medical devices including metallic films
US20100204784A1 (en) * 2005-05-16 2010-08-12 Boston Scientific Scimed, Inc. Medical devices including metallic films
US8152841B2 (en) 2005-05-16 2012-04-10 Boston Scientific Scimed, Inc. Medical devices including metallic films
US20060259131A1 (en) * 2005-05-16 2006-11-16 Masoud Molaei Medical devices including metallic films and methods for making same
US9078632B2 (en) 2010-02-26 2015-07-14 ProMed, Inc. System and method for vessel access closure
US8870937B2 (en) 2010-02-26 2014-10-28 ProMed, Inc. Method for vessel access closure
US8906080B2 (en) 2010-02-26 2014-12-09 ProMed, Inc. System and method for vessel access closure
US20110213412A1 (en) * 2010-02-26 2011-09-01 ProMed, Inc. Apparatus for vessel access closure
US20110213411A1 (en) * 2010-02-26 2011-09-01 ProMed, Inc. Method for vessel access closure
US20110213410A1 (en) * 2010-02-26 2011-09-01 ProMed, Inc. Method for vessel access closure
US9439635B2 (en) 2010-02-26 2016-09-13 ProMed, Inc. Method for vessel access closure
US9445796B2 (en) 2010-02-26 2016-09-20 ProMed, Inc. Method for vessel access closure
US9775592B2 (en) 2010-02-26 2017-10-03 ProMed, Inc. System and method for vessel access closure
US10039534B2 (en) * 2010-02-26 2018-08-07 ProMed, Inc. Apparatus for vessel access closure
US10039535B2 (en) 2010-02-26 2018-08-07 ProMed, Inc. System and method for vessel access closure
US20160158039A1 (en) * 2013-05-03 2016-06-09 Acandis Gmbh & Co. Kg Medical device for inserting into a hollow organ of the body
US9855157B2 (en) * 2013-05-03 2018-01-02 Acandis Gmbh & Co. Kg Medical device for inserting into a hollow organ of the body

Also Published As

Publication number Publication date
US20110144740A1 (en) 2011-06-16
US20150039077A1 (en) 2015-02-05
US8864815B2 (en) 2014-10-21
US9833310B2 (en) 2017-12-05
US7901447B2 (en) 2011-03-08

Similar Documents

Publication Publication Date Title
US9833310B2 (en) Medical devices including metallic film and at least one filament
US8632580B2 (en) Flexible medical devices including metallic films
CA2558132C (en) Medical devices including metallic films and methods for making same
US20150190255A1 (en) Medical devices including metallic films and methods for making same
US8152841B2 (en) Medical devices including metallic films
US20050197687A1 (en) Medical devices including metallic films and methods for making same
US7749264B2 (en) Medical devices and methods of making the same
US20060142838A1 (en) Medical devices including metallic films and methods for loading and deploying same
EP1877112B1 (en) Medical devices and methods of making the same
WO2006071242A1 (en) Medical devices including metallic films and methods for making same
US8435280B2 (en) Flexible stent with variable width elements
WO2006071245A1 (en) Medical devices including metallic films and methods for loading and deploying same
WO2006071244A1 (en) Medical devices including metallic films and methods for making the same
US8992592B2 (en) Medical devices including metallic films
WO2006071243A1 (en) Medical devices including metallic films and methods for making same
JP6960110B2 (en) Stent

Legal Events

Date Code Title Description
AS Assignment

Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MOLAEI, MASOUD;CORREA, BEREN W.;REEL/FRAME:016083/0564

Effective date: 20050315

STCF Information on status: patent grant

Free format text: PATENTED CASE

CC Certificate of correction
FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 4

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 8

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 12TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1553); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 12